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Abstract 
The purpose of this study was to extend previous literature of the BDI-FastScreen 
and demonstrate a more empirical clinical utility within a sample of patients with pain. 
This study utilized existing data found in a large, multiphysician, multilocation pain 
management practice. The sample consisted of 328 male and female patients with pain. 
Various psychometric analyses were performed.  Results pertaining to the internal 
consistency of the BDI-FastScreen determined the items most highly correlated were 
pessimism and loss of pleasure.  A factor analysis revealed 49.18 % of the variance of the 
factor structure of the BDI-FastScreen was comprised of one factor. Gender was 
investigated as a moderator of depression and pain and although gender was not 
demonstrated to moderate the pain / depression relationship, there was a clear 
relationship between pain and depression. There was a significant correlation between the 
physicians’ rated depression score and patients’ corresponding, self-reported depression 
scores on the BDI-FastScreen. Researchers compared patients’ self-rated depression 
scores and depression descriptors embedded within another measure. A significant 
correlation between the BDI-FastScreen scores and the items on a derivative of the SF-
MPQ was found. All the correlations were significant, confirming the supposition that 
breaking down the seven items into descriptors and embedding the descriptors into a 
different measure adequately assesses for depression.  
Results of this project demonstrate the BDI-FastScreen can be condensed to one 
word descriptors and adequately assess for depression in a population with chronic pain. 
Instead of utilizing the data from two distinct measures, the adapted patient encounter 
v 
 
form, a derivative of the SF-MPQ and BDI-FastScreen, both clinical disorders can be 
expeditiously and adequately assessed. This study will provide physicians and clinical 
health psychologists with diverse insights and the ability to utilize multiple depression 
measures to provide insightful treatments for their patients.  
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Epigraph 
 
 
The mind is everything; what you think, you become.  
Buddha  
Chapter 1 
Statement of the Problem 
Rates of depression are higher in populations of general medical patients when 
compared to individuals not seeking treatment for a general medical condition (Clark, 
Cook, & Snow, 1998; Freeman, Lightner & Golden, 2010). Coexisting depression 
symptoms can exacerbate medical symptoms and negatively affect social adjustment and 
future recovery. A single depressive episode can present a potential risk for future 
episodes of depression. Depression symptoms though, are not always easy to diagnose as 
depression specific.  Neurovegetative and somatic symptoms in depression 
symptomatology may overlap with symptomatology found in other medical illnesses, 
thereby leaving depression difficult to identify and diagnose (Freeman et al 2010). In 
patients with chronic pain, for example, depression has been established as the most 
common comorbid condition (Poole, Bramwell, & Murphy, 2006; Tennen, Affleck, & 
Zautra, 2006).  
In the United States, pain is one of the most prevalent reasons for seeking medical 
care.  Gatchel and Oordt (2004) estimated that more than 50 million Americans seek 
medical attention for regulation of pain symptoms each year, with pain symptoms 
accounting for more than 80% of all physician visits. According to Turk and Burwinkle 
(2005), within a specified 3-month period, approximately 200 million American’s report 
a recent episode of low back pain, migraine pain, or neck pain. With the high rate of 
individuals seeking control of pain and a high rate of depression comorbidity, the ease of 
recognition and subsequent treatment of both disorders may be subsumed.  
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Pain-clinic statistics report prevalence rates of depression ranging from 30-54% 
(Poole, et al., 2006). In the population with chronic back pain for example, depression is 
a common concomitant factor with a prevalence rate, that may be higher than 52% 
(Wesley, Gatchel, Garofalo, & Polatin, 1999). Depression has been demonstrated to 
complicate the prognosis for patients with chronic pain; yet, there are similarities in 
diagnostic criteria between depression and chronic pain (Poole, et al., 2006).  Specific 
examples include somatic symptoms, such as sleep disturbances, and quality-of-life 
indicators, such as loss of interest in previously enjoyable activities.  The connection 
between pain and depression is further exemplified in areas of other areas of somatic 
function and negative views of self  (Tennen, et al., 2006; Zlot, Herrmann, Hofer-Mayer, 
Adler, & Adler, 2000).  Additional research also has determined that depression 
influences pain and that pain can predict a depressive episode in individuals with a prior 
history of depression (Tennen, et al., 2006). These reciprocal influences demonstrate an 
established connection between depression and chronic pain.    
The concomitant relationship between depression and chronic pain 
symptomatology has been well established (Poole, et al., 2006;Tennen, et al., 2006; 
Wesley, et al., 1999). For example, previous research has established the benefits of early 
intervention techniques to target depression (Dysvik, Natvig, Eikeland, & Lindstrom, 
2005). Identifying negative health habits, such as smoking or drinking alcohol, 
identifying detrimental behavioral activities and distorted thinking that may accompany 
both depression and chronic-pain symptomatology, may facilitate a better prognosis and 
minimize recovery time. Therefore, an integrated measure targeting depression and 
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chronic pain will enhance diagnostic abilities and afford the patient the benefit of early 
depression detection.   
Depression is related to sensory, emotional and cognitive factors of pain. 
Assessing for depression at the outset of treatment and throughout the course of treatment 
may help clinicians to detect behavioral activities, distorted thinking and negative health 
habits that may assist them in understanding the patient in a comprehensive manner.   
Purpose of the Study 
The purpose of this study is to determine the factor structure and psychometric 
properties of the Beck Depression Inventory-FastScreen in a sample of patients with pain. 
Research clearly indicates that the rates of depression are higher in general medical 
patients with a concomitant high comorbidity of psychological disorders than those 
without the existing comorbidity. The reciprocal influences of pain and depression, such 
as negative emotions and a decrease in activity level, serve to perpetuate aspects of both 
disorders.  The Beck Depression Inventory-II (BDI-II) is the most prevalent measure 
used to identify depression. Using the BDI-II as a foundation, the BDI-FastScreen was 
developed to factor out neurovegetative signs of depression found in a medical 
population and concentrate on those factors of depression that relate soley to depression. 
This measure was specifically developed to factor out co-occurring depression 
symptomatology that may be related to a medical condition (Steer, Cavalieri, Lenonard, 
& Beck, 1999). 
Most physicians, including family practitioners, psychiatrists and pain specialists, 
may fail to identify symptomatology as depression specific (Clark, Cook, & Snow, 1998). 
Depression within the pain population can exacerbate medical symptoms thereby 
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negatively affecting social adjustment and future recovery (Clark, et al., 1998). An 
episode of depression can increase the probability of future episodes of depression.  
Although the BDI is the most common measure administered to assess depression in the 
general medical population, the amount of research validating the psychometric 
properties of this measure within the pain population is limited.  Therefore, this study will 
examine the factor structure of the BDI-FastScreen within a sample of patients with pain 
and evaluate how this measure relates to patient and physician appraisal, demographic 
information, and characteristics of the individual patient with pain, such as age, gender, 
diagnosis, onset, and duration. 
This study will serve to provide physicians and clinical health psychologists with 
diverse insights into patients with pain and the ability to utilize multiple depression 
measures to provide meaningful treatments for their patients. The concomitant 
relationship between depression and pain symptomatology has been well established in 
previous research (Poole, et al., 2006; Tennen, et al., 2006; Wesley, et al., 1999). The 
benefit of early intervention techniques targeting depression symptomatology has also 
been established (Dysvik, et al., 2005). Identifying distorted thinking, detrimental 
behavioral activities and negative health habits that may accompany both depression and 
pain symptomatology may facilitate a better prognosis and minimize convalescence time. 
Therefore, an integrated patient profile targeting depression and pain will enhance 
diagnostic abilities and afford the patient the benefit of early depression detection.  In the 
context of routine pain-management treatment, if physicians in a multidisciplinary pain 
practice can promptly and accurately detect and identify patients with a comorbid 
depression episode, the current pain episode potentially could be minimized.   
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Chapter 2 
In the United States, major depression is a principal cause of disability and is 
estimated to occur in approximately 4% of the general population (Ohayon & Schatzberg, 
2003). However, this specific estimate of depression is augmented when there is a 
concentrated focus on a precise aspect of the general population. Specifically, when 
general medical patients are examined and compared with a population of individuals not 
receiving treatment, for example, the medical population exhibits an increased rate of 
depression symptomatology (Clark, et al., 1998). Researchers have demonstrated that 4% 
of a sample of 20,000 individuals met the criteria for a depression diagnosis.  Within the 
same population, it was further demonstrated that 16.5% of the total number of 
participants reported a minimum of one depression symptom (Ohayon & Schatzberg, 
2003).   
Depression Comorbidity 
Depression is a psychological disorder that affects individuals across their 
lifespan.  Depression knows no boundaries and can affect children, adolescents, adults, 
and elderly individuals.  The symptomatology indicative of depression includes somatic 
complaints, physical symptoms, and feelings of sadness, loneliness, hopelessness, and 
agitation. Mental health problems are frequently encountered in primary-care 
(DiTomasso, Golden & Morris, 2010).  Diagnosing depression within the primary-care 
setting raises its own set of difficulties. When presented to a primary-care specialist, 
individuals most commonly describe somatic manifestations of depression, such as pain, 
anhendonia, and difficulty sleeping.   
6 
 
When individuals with a general medical condition have a comorbid diagnosis of 
depression, many facets of the psychological symptomatology, may serve to impede, a 
recovery from the medical disorder. Specifically, psychological symptomatology can 
exacerbate medical symptoms thereby negatively affecting social adjustment and future 
recovery. Additionally, one episode of depression may elevate the risk for future episodes 
of depression. Neurovegetative and somatic symptoms found in depression 
symptomatology often overlap with symptomatology found in other medical illnesses 
thereby leaving depression difficult to identify and diagnose. Researchers have estimated 
that approximately 52 % of individuals being treated in a pain clinic will fit the 
diagnostic criteria for both pain and depression (Bair, Robinson, Katon, & Kroenke, 
2003).  This number is higher in other medical settings. Particularly within an orthopedic 
setting and in a dental clinic, as many as 56 % and 85 %, respectively, of patients have a 
comorbid pain and depression diagnosis (Bair, et al., 2003).   
Consquently, individuals being treated for a pervasive medical condition are more 
susceptible than individuals not being treated, to simultaneously develop depression 
symptomatology (Clark, et al., 1998).  Broadening the terms of pervasive medical 
conditions also to encompass a general medical population, researchers believe a higher 
number of general medical patients are at an increased risk for developing subclinical 
symptomatology (Clark, et al., 1998).   
Depression and gender. Although contextually the manifestation of depression 
symptoms has been established, there are additional prevalent differences.  For example, 
depression may present differently between genders. Women endorse symptomatology 
such as depressed mood, crying and guilt (Sloan & Sandt, 2006).  Men, on the other 
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hand, typically report feelings of anger (Sloan & Sandt, 2006). Thus the type and 
manifestation of depression symptomatology have been demonstrated to be different 
between genders.  
The prevalence of depression between genders is also different. The lifetime 
prevalence rates of depression are different for adult men versus women. A 1993 review 
of the National Comorbidity Survey revealed a lifetime prevalence rate of depression at 
12 % higher for women than men (Kessler, McGonagle, Swartz, Blazer, & Nelson, 
1993). Women tend to have a higher lifetime prevalence rate, further indicating increased 
rates of depression.  Kessler et al. (1993) have shown that women have a 17.1 % lifetime 
prevalence rate of a major depression disorder. 
Women are diagnosed with depression at more than twice the rate that men when 
diagnosed with the same disorder  (Culbertson, 1997; Sloan & Sandt, 2006).   
Specifically, it has been reported that adult females are diagnosed with depression at a 
rate of 22.4% when compared to adult males who are diagnosed at a rate of 13.9 %  
(Angst, Gamma, Gastpar, Lepine, Mendelwicz, & Tylee, 2002). Depression affects at 
least twice the number of women than men. This difference appears to be relatively 
consistent across a wide range of cultures, with an average of female patient to male 
patient ratio of 2:1 (Immerman & Mackey, 2003) 
There are some factors, such as education level and abuse history, that may 
influence the chances of developing depression.  Education is one construct that appears 
to factor into the development of a depression diagnosis.  In a 2007 study, researchers 
found that, post cardiac surgery, women with a higher education level were diagnosed 
less frequently with depression than women with a less education (Doering, Cross, 
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Magsarili, Howitt, & Cowan, 2007).  Also, women with an early abuse history are more 
likely to develop depression when compared to women without an early abuse history 
(Nolan, 2000).  
Pain as the Most Prevalent Reason to Seek Medical Attention 
In the United States, pain is one of the most prevalent explanations for seeking 
medical care.  Gatchel and Oordt (2004) estimate that more than 50 million Americans 
seek medical attention for regulation of pain symptoms each year. However, a later study 
reports a much larger number.  In a 2005 report, Turk and Burwinkle stated that in a 3-
month period, approximately 200 million Americans reported a recent episode of low 
back pain, migraine pain, or neck pain. Pain symptoms account for a majority of 
physician visits, often more than 80% of all physician visits are derived from a pain 
episode. Turk and Burwinkle estimated that the prevalence of individuals seeking 
treatment with pain management physicians is close to half of the general population. 
They further estimated that approximately 2.9 million Americans are treated annually for 
a pain-related experience. This number is higher when other treatment modalities such as 
visiting a primary-care physician, choosing alternative medicine modalities, or utilizing 
over-the-counter medications, are sought to reduce some of the symptomatology. The 
average cost to the American health-care system of treating chronic pain is estimated to 
be between $100 and $150 million each year (Turk & Burwinkle, 2005).  In addition, 
individuals with pain-related disability often miss work as a result of elevated levels of 
pain. Thus, pain-related disability coupled with medical costs is estimated to reach about 
$70 billion dollars annually (Gatchel, 2001).   
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 The Joint Commission on Accreditation of Healthcare Organizations (JCAHO) 
now requires physicians to consider pain to be the fifth vital sign. In addition to blood 
pressure, pulse, body temperature, and respiration rate, the severity of pain must be 
documented. Although allowing for and documenting these vital signs is essential, no 
capabilities presently exist to measure pain. Using a pain scale to identify the severity of 
the pain episode is imperative; however, other issues also need to also be assessed.  For 
example, in a comprehensive evaluation, the physical location of pain, the onset of pain 
symptoms and factors contributing to the aggravation or the alleviation of pain need to be 
elucidated.  To complete the evaluation of pain, the individual must define a pain goal.  
Together with a physician appraisal of the pain, these components are collected and 
compiled for a complete evaluation of the pain episode.  
The experience of pain. The pain experience as a whole is subjective. The 
subjectivity of the pain experience is composed of sensory, emotional and cognitive 
factors.  Past experiences with pain leave a lasting impression and may also contribute to 
the intensity of pain. Feelings that accompany a pain event define the emotional construct 
forming the context of that pain event. Intensity, location, duration and quality of pain are 
sensory-level dimensions that need to be assessed. The patient’s perception and 
terminology in describing the actual neurological pain event are important factors in 
understanding the patient’s current pain experience (Gatchel & Oordt, 2004).  Awareness, 
memory, and expectations are three concepts that contribute to the individual’s 
perception of pain. Therefore, the physician must pay attention to the exact terminology 
used by the patient because specific terms can alert the physician to signs of depression, 
stress and anxiety. Augmented levels of stress and anxiety have been linked to augmented 
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pain intensity (Gatchel & Oordt, 2004). Delineating the unpleasant emotion within a pain 
episode is a difficult task as the onset of pain is typically the result of a threatening event. 
Some research has shown that the amount of negative symptomatology is linked to the 
intensity of pain (Price, 2000). 
What Is Pain? 
Throughout the years, there have been differing theories identifying the 
physiological basis of pain. The predominant theory of pain, put forth in the 1960s, and 
known as the gate control theory of pain, was developed by Melzack and Wall 
(Campbell, Clauw, & Keefe, 2003; Gatchel, 2005).  The gate control theory of pain 
identified a multi-system evaluation of the pain experience.  The perception of pain, as it 
is experienced, is transmitted to the brain along a neural pathway. The pain perception 
reaches the brain via the dorsal horn.  The dorsal horn functions as a gating mechanism 
that transposes the pain perception to a pain sensation. The gating mechanism can be 
regulated by thoughts, feelings and behaviors.  
As a beneficial foundation for understanding the physiological basis for pain, the 
gate control theory of pain introduced a relatively innovative manner by which to view 
pain. Melzack and Wall were the first to identify the importance of thoughts, feelings, 
and behaviors as they relate to the pain experience (Gatchel, 2005). Taking an innovative 
perspective on pain, the gate control theory of pain can be viewed as the first theory to 
consider psychosocial factors as they relate to pain (Gatchel, 2004).   
In a later theory, Melzack (2005) expanded the gate control theory of pain to 
include models of stress and a diverse network of nerve impulses (Gatchel, 2005; 
Melzack, 2005).  Melzack identified a more elaborate mechanism responsible for a pain 
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experience.  He postulated that pain is a multidimensional construct based on the 
physiological make-up of nerve fibers that run parallel to one another (Melzack, 2005). 
He theorized that the psychological basis of pain is extensive and that many factors, such 
as genetic factors, situational factors, and sensory experiences can influence pain.  
In his neuromatrix theory, Melzack (2005) refered to the neurons that link the 
thalamus to the cortex and the cortex to the limbic system as the neuromatrix.  The 
neuromatrix is the seminal mechanism for identifying and imprinting the sensation of 
pain as it focuses on all aspects of a pain experience, namely, vestibular, visual and 
somatosensory sensations. Melzack accounted for individual differences in the 
establishment and maintenance of pain for each person. Gatchel (2005) suggested that a 
pain experience can be viewed as an acute stressor where the pain episode exacerbates 
other symptoms of pain thereby establishing the pain as a stressor.  In an effort to return 
to homeostasis, the pain experience elicits a fear response.  The fear response perpetuates 
the cycle by augmenting the stress response of the body (Gatchel, 2005).   
The biopsychosocial model of pain is the first pain theory to incorporate 
physiologic, psychological and social factors as constructs that serve to maintain and/or 
perpetuate pain (Gatchel, 2005). This theory extends the previous discernment of pain by 
extending the comprehension of pain.  The biopsychosocial model of pain includes the 
manner in which pain interacts on both a physiological and a psychological basis. The 
foundational underpinnings of this theory explicate a complex relationship of factors that 
serve to both maintain and perpetuate pain (Gatchel, 2001). Therefore, the 
biopsychosocial understanding of pain indicates that a physiopsychological assessment of 
pain is essential as an independent evaluation of physical or psychological components is 
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impossible (Gatchel, 2001).  The biopsychosocial model of pain has been established as 
the most heuristic theory with which to conceptualize pain (Gatchel, 2005).   
Definition of chronic pain.  A chronic-pain diagnosis is multidimensional and, as 
such, affects the patient on many different levels. Within a pain episode, there are 
multiple dimensions of the pain, and each of the manifold implications of pain 
contributes to the experience in a diverse fashion. Within each experience, several 
different aspects of pain have the potential to affect the individual. Physiological 
implications, such as somatic and sensory factors, are features of pain that can interfere 
with activities of daily functioning. The affective dimension of pain contains the constant 
unpleasantness and emotional reaction to the pain as presented on a short-term basis. 
Subsequent to the affective dimension of pain lies the secondary affect of pain. This 
secondary affect of pain is termed from the characterizations of thoughts, such as 
unpleasantness and perceived forthcoming implications of pain, such as long-term 
suffering (Price, 2000).   
Physical and psychosocial variables are impacted by chronic pain (Dysvik et al, 
2005). There is a diverse manner in which pain affects an individual in a physical 
manner. For example, chronic pain may have an impact on the patient’s physical 
behavior.  The physical manifestations of the pain symptoms, also known as pain 
behaviors, may impede activities and have an overall restrictive effect on daily living. 
Individuals may no longer be able to continue in the same occupation, complete childcare 
tasks, or perform household chores. Sleep may be affected, possibly as a result of 
medication or lack thereof. Anxiety symptomatology manifesting in conjunction with the 
pain symptomatology or as a set of separate symptoms also may be present.   For 
13 
 
example, pain can affect the manner in which an individual thinks and processes 
information, the manner in which an individual acts and reacts to situations, and the 
manner in which an individual physiologically responds to the pain.  
Behaviorally, the individual may avoid situations because of the potentiality of 
experiencing pain.  Another possibility for the individual’s choosing to avoid situations 
that were previously pleasurable could be the deleterious effects of pain (Banks & Kerns, 
1996).  In part because of the pain, or the prodromal incident resulting in the chronic-pain 
state, the patient may not be able to engage in a previously established level of intimacy, 
sexual relations or normal exercise regimen. As the individual’s previous level of 
functioning and participation in pleasurable activities continues to diminish, the 
individual often experiences more depressive symptomatology.   
As the individual continues to endure the deleterious multidimensional 
ramifications of the experience of pain itself, deficits in other aspects of functioning are 
often found. For example, a 2003 study found a concomitant deficit in coping skills 
(Campbell, Clauw, & Keefe).  This study identified an association between pain and 
maladaptive coping skills, specifically citing pain as a precursor to maladaptive coping 
skills (Campbell et al, 2003).  Previous research has demonstrated a link also between 
pain and psychological disorders. Specifically, Banks and Kerns (1996) highlighted the 
ramifications of enduring consistent exposure to pain. These authors speculate that 
consistent exposure to pain may lead to a breakdown in effective coping mechanisms and 
negatively impact the psychological state of the individual (Banks & Kerns).  
Diagnosis of Chronic Pain.  There are differing definitions of what constitutes 
chronic pain; however, the physician typically guides the standard definition.  A 
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diagnosis of chronic pain is made after the physician deems the patient to have fulfilled 
specific requirements, the first of which is duration. Chronic pain may be diagnosed after 
a pain episode has lasted for 6 months or longer.  Although the physician reserves the 
right to use clinical judgment, the patient’s self-report of pain longevity is heavily 
weighed.  Pain quality and the extent of daily impact are further considerations. The 
quality of pain needs to be of moderate to severe intensity, and the pain must significantly 
affect daily living (Dysvik et al, 2005).  Although terminal illnesses often encompass a 
chronic-pain component, a chronic-pain diagnosis is not given when the pain occurs in 
conjunction with a terminal illness. Given the multifaceted dimensions associated with 
pain and the impairment it can cause on daily living, pain can lead to more pain and often 
becomes a lifelong concern. Despite medical advances and available pharmacological 
interventions, most individuals diagnosed with chronic pain are not fully cured and hence 
will endure the pain into the future (Turk & Burwinkle, 2005).  
Typically viewed as an aversive sensation by anyone inflicted with pain, a pain 
episode is regarded as a deleterious event with an identifiable biological basis. Pain itself 
can be indicative of a medical illness thereby causing an individual to look for an 
underlying medical causation of the pain. Chronic pain often signifies to an individual 
that the pervasive and constant pain may be resulting from a medical illness (Campbell et 
al, 2003). Pervasive and constant pain is not always perceived as a medical illness in and 
of itself; therefore, individuals within this population may need some assistance in 
identifying and addressing some of the ramifications of pain.   
Individuals enduring persistent pain have been shown to demonstrate deficient 
coping strategies (Campbell et al, 2003).  For example, one particular maladaptive coping 
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strategy, catastrophizing, has been linked with elevated rates of depression as well as 
with augmented rates of pain (Campbell et al., 2003). Potentially, the low self-efficacy 
these individuals have developed translates to the maladaptive coping strategies the 
individuals implement to combat the negative state of depression and the unpleasantness 
of the pain episode. Learned helplessness, another identified maladaptive coping strategy 
also has been linked to higher levels of pain and depression symptomatology, as 
individuals believe they do not have the ability to manage pain or combat depression 
(Campbell et al., 2003). In a population of pain patients with neuropathic pain, 
helplessness as a specific component of catastrophic thinking is perhaps the most 
concerning maladaptive coping strategy (Sullivan, Lynch, & Clark, 2005). Research has 
demonstrated that in one particular sample of patients with rheumatoid arthritis, the 
individuals who significantly overcatastrophized their pain levels also reported 
augmented levels of depression (Campbell et al., 2003). The most significant predictor of 
future pain is a feelings of helplessness.  Within the helplessness dimension, catastrophic 
thinking was found to be a significant predictor of pain (Sullivan et al., 2005).  In fact, 
catastrophic thinking related to pain is purported to serve as a psychological correlate and 
continue to be a source of disability in pain patients.  
Rainveille, Carrie, Hofbauer, Bushnell, and  Duncan (1999) reported a 
relationship between the perception of pain and physiological responses.  Following 
merely a suggestion of a palliative substance, pain ratings decreased. Alternatively, when 
pain was suggested, the psychophysiological response increased.  Unconscious pain 
suggestion increased both the perception of pain and the emotional symptomatology with 
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no apparent alteration of pain intensity (Rainville, Carrie, Hofbauer, Bushnell, & Duncan, 
1999).   
Objective/subjective measurement of chronic pain.  Similar to the behavioral 
aspect of dealing with chronic pain, affective and emotional constructs are other areas of 
change the patient may experience. Living with physical pain is likely to have an impact 
on coping skills and reasoning abilities, as well as on participation in social activities. 
Effectively measuring the pain is imperative in order to facilitate a diagnosis and 
successfully measure the treatment progress (Grafton, Foster, & Wright, 2005).  In 
addition to assessing pain levels, vital components imperative in adequately pain 
evaluation also include an assessment of disability and impairment (Gatchel, 2005).   
One of the most common assessment tools used by physicians in a chronic-pain 
clinic, multidisciplinary practice, or pain-management practice, one of the most common 
assessment tools used by the physicians, is the McGill Pain Questionnaire (MPQ; Grafton 
et al., 2005).  Developed by Melzack (1987), this measure was created to provide 
―valuable information on the sensory, affective, and evaluative dimensions of pain 
experience and is capable of discriminating among different pain problems‖ ( p. 191). 
The completion of the MPQ requires between 15-20 minutes, which could be a struggle 
for some patients with chronic pain to complete expeditiously. Although some patients 
have reported have difficulty understanding the meaning of the vocabulary within the 
measure, the validity of the MPQ has been established by numerous studies (Grafton et 
al., 2005).   
Taking both the time factor, and the complicated language of the MPQ into 
consideration, Melzack (1987) developed a shortened version of his original MPQ. 
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Melzack used some of the key descriptors from his original MPQ and developed the 
Short Form-McGill Pain Questionnaire (SF-MPQ). The self-administered SF-MPQ is 
used in both the clinical capacity and the research capacity and has an improved clinical 
utility (Grafton et al., 2005). The SF-MPQ was designed to adequately assess the 
affective and sensory modalities of pain that the patient is experiencing; however, there is 
no supportive research substantiating the factor structure (Grafton et al., 2005).  There 
have been, however, studies supporting the criterion validity between the original MPQ 
and the SF-MPQ. Additionally, the SF-MPQ has demonstrated excellent reliability in the 
overall score as well as in the following specific categories: sensory, affective, and 
average pain level.   
Treatment of Chronic pain 
The current research on chronic pain provides information on the longevity and 
multidimensional nature of chronic pain.  This research, although informative, further 
complicates treatment of chronic pain. The patient not only is living with constant pain 
that is oftentimes debilitating and life changing, but also is subjected to unfavorable 
scrutiny by others. Patients report that judgmental questioning regarding the medication 
portion of their treatment regimen often affects their medication compliance. While the 
medication may be helpful in assuaging some of the physiological aspects of pain, the 
questioning may be regarded as disparaging by the patient and unintentionally may 
instigate discontinuance of a medication (McCracken, Hoskins, & Eccleston, 2006). The 
noncompliant with the medication regimen may be followed by an exacerbation of pain 
symptomatology.  
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Pharmacological interventions for pain are often confounded by other factors. 
Medication use within the population with chronic pain is an established modality of 
treatment. McCraken et al., (2006) reported that medication used by the population with 
chronic pain becomes second nature and part of a routine. These authors continue by 
reporting that the choice to utilize pain medication is multiply determined.  One 
determinant is personal and cultural morals influenced by beliefs.  Affective 
manifestations and physiological responses also affect the decision. Patients with chronic 
pain are given medications to alleviate their physical pain sensation. These authors 
suggest the medication becomes habitually linked to the emotional mood of the patient as 
well thereby leading to a reliance on the medication. An increasing number of patients 
with chronic pain, slightly less than 50%, have expressed concern about a potential 
addiction to the prescribed pain medicine.  Approximately 49% of the same population 
reported being suspicious of the physician responses they received regarding this 
particular treatment modality (McCracken et al., 2006).   
Unfortunately, for a majority of chronic-pain sufferers, significant pain 
assuagement is not found.  Traditional medicine, pharmacological interventions, surgical 
procedures, and even regional anesthesia may not relieve the pain (Turk & Burwinkle, 
2005).  Learning to adapt to their new situation and regain a homeostatic balance has 
been shown to be beneficial for these patients. Frequently chronic pain is exacerbated by 
poor adaptation to the pain situation, which in turn may lead to depression 
symptomatology, such as poor self-esteem (Dysvik et al., 2005). Depression, in turn, may 
lower the pain threshold and tolerance to pain (Zlot et al., 2000). Depression itself may 
hinder effective coping mechanisms. Treating the psychological basis of pain, therefore, 
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may assist in controlling the development of excessive pain symptomatology. Hence, to 
deal effectively with chronic pain, the individual must implement a new set of coping 
mechanisms (Dysvik et al., 2005).  One effective manner through, which an individual 
can establish superior coping mechanisms is (CBT).  Diverse cognitive and behavioral 
focused treatment modalities have been demonstrated to be efficacious for a population 
of patients with pain (Keefe, et al., 2000).  In this context, CBT is useful to patients with 
pain by assisting them to reframe their perspective of pain and the subsequent impairment 
(Golden, Gatchel, & Glassman, 2010).  For example, in a controlled study, daily 
observed pain scores were found to be lower in a group of adults with chronic fatigue 
syndrome after a course of CBT (Knoop et al., 2007).  Researchers in the same study also 
found augmented activity levels in both adults and adolescents at the conclusion of CBT. 
The resulting data suggests that CBT treatments targeting negative thinking patterns can 
allay those negative cognitions and alleviate the total number of pain locations (Knoop et 
al., 2007).   
Other types of CBT modalities have been shown to be efficacious as well.  
Altering the manner in which an individual perceives his or her pain by assisting the 
individual in understanding the role of thoughts, beliefs, and expectations as they relate to 
pain levels has resulted in positive outcomes (Campbell et al., 2003).  Transforming 
cognitions aimed at alleviating pain and depression symptomatology has been shown to 
be beneficial in reducing the overall pain symptomatology (Campbell et al., 2003).  When 
comparing a group of patients with pain being treated with CBT to a group of patients 
with pain being treated both pharmacologically with amitriptyline, and non-CBT therapy, 
results demonstrated that the group of patients being treated with CBT demonstrated the 
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most efficacious results (Campbell et al., 2003).  A recent review of 35 multidisciplinary 
pain practices found the integrated approach, with CBT as a component, was superior to 
medical treatment alone (Scascighini, Toma, Dober-Spielmann, & Sprott, 2008).   
Certain disorders on the pain spectrum are thought to be allied with changes in the 
central nervous system and thus indicate that psychosocial factors are influential 
components of the management of pain symptomatology (Campbell et al., 2003).  Hence, 
CBT can be especially efficacious with disorders such as these.  Specifically, disorders 
such as chronic fatigue syndrome, irritable bowel and fibromyalgia were found to have 
efficacious results when treated with CBT (Goldenberg, Burckhardt, & Crofford, 2004; 
Sharpe, 1998; Spiller et al., 2007).  
To implement a new set of coping mechanisms, to relieve some of the depressive 
symptoms, and to assist in alleviating some of the chronic pain, the physician needs to 
recognize the depression and treat it as quickly as possible. Multidisciplinary pain-
management teams have been found helpful with all of these difficulties (Turk & 
Burwinkle, 2005). 
Multidisciplinary Pain Management Teams 
Multidisciplinary pain-management teams typically consist of a physician, 
psychologist, midlevel provider, nurse, support staff, the patient and the patient’s family.  
Together, the members of the team target the pain as an interrelated, complex unit. 
Psychosocial factors related to pain are targeted areas of treatment. Typically these 
programs implement CBT techniques to minimize the risk of psychological effects and to 
foster the forward motion of progress. Additionally, CBT will assist the patient in 
implementation of psychoeducational and behavioral strategies.  
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Comorbidity of Psychological Disorders 
In patients with chronic pain, depression has been established as the most 
common comorbid condition (Poole et al., 2006; Tennen et al., 2006; Turner & Romano, 
1984).  The connection between preexisting depression symptomatology and subsequent 
pain episodes has been a well-established (Romano & Turner, 1985).  The same research 
identifies co-occurring depression and pain symptomatology (Romano & Turner, 1985).  
Pain-clinic statistics report, the prevalence rates of depression ranging from 30 %-54% 
(Poole et al., 2006).  In a population of patients who suffer from chronic back pain, for 
example, depression is a common concomitant factor, with a prevalence rate as high as 
52% (Wesley et al., 1999). Episodes of back pain have been reported to be significant 
predictors of major depression (Currie & Wang, 2004). A study showed that 25.8 %-
43.8% of a population of Hungarian women aged from adolescence to early adulthood 
reported a history of chronic headaches or musculoskeletal pain; 10 % of those women in 
that sample also reported depression symptomatology (Rethelyi et al., 2004).  
Reciprocal influences. There is a high correlation of physiological components 
shared between depression and pain (Banks & Kerns, 1996).  For example, common 
concomitant symptoms include sleep disturbances and anhedonia (Sullivan, Reesor, 
Mikail, & Fisher, 1992). Also, depression may manifest as an aching pain, such as a 
backache or a headache.  As this symptomatology is present in both pain and depression, 
identifying the etiology of the symptoms may be difficult.  This difficulty further 
complicates the diagnosis and treatment. Therefore, the inaccuracy in identifying pain 
versus depression symptomatology resulting from indistinguishable symptoms, may lead 
to the inconsistencies in these findings (Brown, 1990).   
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There is a significant overlap in symptomatology when patients present in 
medical offices (Campbell et al., 2003). The overlap and similarity between pain and 
depression symptomatology often confound the diagnosis of depression and contribute to 
the arduousness of making the diagnosis. Pain is often a stressor that contributes to the 
instigation of an episode of major depression (Banks & Kerns, 1996).  The pain 
experience itself is sometimes viewed as the instigating event that precipitates a mood 
episode  (Currie & Wang, 2004; Ohayon & Schatzberg, 2003).  The pain and depression 
relationship can be reversed and a depressive episode can be regarded as a precursor to a 
pain episode (Ohayon & Schatzberg, 2003).  
The strength of the relationship between pain and depression has been 
demonstrated to become more intense when pain develops subsequent to a depressive 
episode and pain has the potential to exacerbate a depressive episode (Rush, Polatin, & 
Gatchel, 2000).   Greater pain levels have been demonstrated to have an impact on the 
longevity of a depressive episode, increasing the length of the symptomatology (Karp et 
al., 2005). Pain levels may increase if either one of the circumstances worsen (Bair et al., 
2003). Lepine and Briley (2004) conducted a meta-analysis demonstrating the significant 
prevalence of depression within a population of patients with pain, both pervasive and 
acute.  Reciprocal influences, the occurrence of pain within a population of individuals 
diagnosed with depression were also demonstrated to be significant (Lepine & Briley, 
2004). Specifically, adolescents diagnosed with depression have been shown to have a 10 
times greater risk of developing headaches when compared to nondepressed adolescents 
(Pine, Cohen, & Brook, 1996). A review of United States health statistics demonstrated 
that depression symptomatology found in an earlier study doubled increased the chances 
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of developing pain by the next review (Magni, Moreschi, Rigatti-Luchini, & Merskey, 
1994).   
The severity of pain also plays a role in the onset and duration of a depressive 
episode.  Lepine & Briley (2004) suggested that chronic pain should be viewed as a 
symptom of depression, and that a full remission of the depressive episode will be 
achieved only subsequent to the assuagement of the pain episode. Therefore, the 
concomitant relationship between pain and depression appears to extend past the onset of 
a mood episode to affect the length of the mood episode as well. For example, Ohayon 
and Schatzberg (2003) found when reviewing a population of people with both pain and 
depression symptomatology, those reporting sadness as an overall mood state were likely 
to identify additional pain symptomatology. This finding suggests that sadness and 
depressive feelings may be more indicative of a depressive episode in a population of 
patients with pain. Researchers in this study also found more than 75% of the study 
participants reported symptoms of depression and pain in equal amounts.  Depressive 
symptomatology was found to be higher in women than in men.  As a result, women were 
also more likely than men to be diagnosed with a mood disorder (Ohayon & Schatzberg, 
2003).  
 Different types of depression and pain symptomatology. Pain and depression 
share a great deal of symptomatology. It is not uncommon to find overlapping symptoms 
thus leading to the laborious job of delineating symptomatology (Banks & Kerns, 1996). 
These concomitant symptoms often interfere with a diagnosis of depression. Bair et al. 
(2003) have shown that depression symptomatology presented in physicians’ offices will 
often manifest in physical complaints, thereby further confounding the diagnosis. The 
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symptomatology indicative of depression that is most often seen in a primary-care 
physician’s office often incorporates patient reports centering on pain symptoms. The 
pain symptoms that are reported contribute to the arduous task of determining a 
depression diagnosis.  The concomitant symptoms that often are guised as complaints of 
pain symptoms typically include fatigue, insomnia and a variety of nonspecific pain 
symptoms.  Research has demonstrated that the likelihood of a depression diagnosis is 
higher when individuals identify multiple physical complaints (Bair et al., 2003).  
Lepine and Briley (2004) suggest that only the psychological aspects of 
depression are assessed in the Diagnostic and Statistical Manual of Mental Disorders.  
These authors question the exclusion and inclusion aspect of pain symptomatology when 
assessing depression symptomatology given the established comorbidity of symptoms 
(Lepine & Briley, 2004).   
Depression diagnosis as an arduous task. Depression will complicate the 
prognosis of chronic pain; yet, there are similarities in diagnostic criteria between 
depression and chronic pain (Poole et al., 2006).  Specific examples include somatic 
symptoms such as sleep disturbances, and quality-of-life indicators, such as loss of 
interest in previously enjoyable activities.  Often, the symptomatology between both 
conditions is similar. Delineating the potentiality of either condition existing 
independently of the other, then, becomes difficult.  Therefore, the primary-care 
physician’s delineation task becomes more arduous (Bair et al., 2003).   
The connection between pain and depression is further exemplified in areas of 
somatic function and negative views of self (Tennen et al., 2006; Zlot et al., 2000).  There 
is a link between depression and unexplained pain (Bair et al., 2003).  Individuals 
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diagnosed with depression often will have higher rates of unexplained pain than 
individuals without depression.  Research has also shown that depression influences pain 
and that pain can predict a depressive episode in individuals with a prior history of 
depression (Tennen et al., 2006). These reciprocal influences demonstrate an established 
connection between depression and chronic pain. Individuals within a depressive episode 
will present more often in a family practitioner’s office with pain symptomatology than 
individuals not in a depressive episode (Bair et al., 2003).  As the pain state itself can be 
viewed as a symptomatic condition it can often confound the identification of depression 
(Banks & Kerns, 1996).   
Shared neurotransmitters.  Although there are numerous neurotransmitters, the 
manner in which many of them affect co-occurring pain and depression symptomatology 
is still unknown.  One study identifies four common neurotransmitters found in both pain 
and depression (Campbell et al., 2003).  Serotonin, for example, has been found to have 
both a pronociceptive and an antinociceptive quality on pain and when levels of serotonin 
are low, this neurotransmitter is linked to elevated rates of depression (Campbell et al., 
2003).  Similar to serotonin, norepinephrine has been shown to demonstrate an 
antinociceptive quality on pain.  When norepinephrine is low, this neurotransmitter is 
linked to a reoccurrence of depression (Campbell et al., 2003; Gold & Chrousos, 2002).  
Substance P also has been demonstrated to be a link between pain and depression. 
Augmented levels of Substance P have been found in psychological disorders and pain 
states as well (Campbell et al., 2003).  When tissue is inflamed, corticotrophin releasing 
factor, a fourth identified neurotransmitter, has been demonstrated to increase rates of 
depression (Bale & Vale, 2003; Campbell et al., 2003).  
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Research by Wells-Federman, Armstein and Caudil ( 2002) has shown a 
correlation between patients with chronic pain and both depression symptomatology and 
depression.  The empirically validated treatment approach to the comorbid disorder of 
depression in the context of chronic-pain treatment is CBT.  The earlier that depression is 
detected and CBT techniques are implemented, the better the prognosis for the patient in 
the overall treatment of chronic pain.  According to Wells-Federman et al. (2002) 
psychoeducation aimed at helping the patient to develop effective coping mechanisms to 
deal with the emotional, cognitive, behavioral and physical aspects of chronic pain may 
help to minimize the course of pain and depression. 
Pain as a precursor to depression. Pain and depression have been established as 
concomitant conditions with comorbidity as high as 30%-54 %  (Poole et al., 2006).  In a 
recent study the comorbidity was found to be 44.5 % and included pain disorders such as 
chronic pain, osteoarthritis and headaches  (Ani et al., 2008).  Throughout the world, 
numerous studies have demonstrated the link between depression and chronic pain. A 
study conducted within a population of patients with rheumatoid arthritis found that this 
group demonstrated significant elevations of depression symptomatology (Brown, 1990). 
This depression finding was further generalized in a different group of patients with 
rheumatoid arthritis. In this subsequent study, results demonstrated that prior to the onset 
of rheumatoid arthritis, one episode of depression puts the individual at risk for 
augmented levels of depression after being diagnosed with rheumatoid arthritis (Vaeroy, 
Tanum, Brauset, Morkrid, & Forre, 2005).  
This finding has been further expounded upon in a wide range of patients with 
pain.  In a recent study conducted in Turkey, women diagnosed with chronic pelvic pain 
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were reported to have higher levels of depression than those in a control group of pain-
free women (Kaya et al., 2006). The depression may be related to sensory, emotional and 
cognitive pain factors. Lewandowski, Palermo, and Peterson (2006) established a link 
between depression and children and adolescents with recurrent head pain and other 
forms of chronic pain. Those authors noted that children and adolescents with a chronic 
form of pain have more difficulty engaging in and completing age-appropriate 
behavioral, mental, and social activities as a result of both their chronic pain and 
depression symptoms. A longitudinal study substantiates these results by identifying 
depression as more common in a group of adolescents additionally reporting chronic 
headaches when compared to nondepressed adolescents (Pine et al., 1996).  Therefore, 
assessing for depression at the outset of treatment and throughout the course of treatment 
may help clinicians to detect behavioral activities, distorted thinking and negative health 
habits that may assist them in understanding the patient in a comprehensive manner.   
Suicidality. Fishbain, Cutler, Rosmoff and Rosmoff (1999) conducted a meta-
analysis of 83 studies.  Specifically delineating the comorbidity of depression in a 
population of patients with chronic pain, they found there was indeed a higher incidence 
of depression within this population.  These authors concluded that the higher incidence 
of depression may foster higher suicidal ideations in this population.  Extending that 
research, Fishbain (1996) then reviewed 18 articles searching for patients with chronic 
pain and suicidality as a corollary.  In addition to depression, there is a symptomatology 
overlap between chronic pain and suicidality. Reported feelings of worthlessness, sleep 
issues and anxiety symptoms were found in both patients with chronic pain and suicide 
attempts and completions.  Fishbain found a higher incidence of suicidality in a 
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population  of patients with chronic pain and concluded that chronic pain may be 
regarded as a risk factor for suicidality and that a psychological consult is imperative 
(Fishbain D. A., 1999).  
Assessment of Depression in a Patient with Chronic Pain  
 A meta-analysis of the prevalence of depression in primary-care practices by 
Pignone et al. (2002) has revealed that two diverse manners of obtaining an appraisal of 
depression symptomatology have proved to be beneficial in detecting depression within 
this population. Two separate but equally brief self-report measures have been deemed to 
be reliable indicators of depression symptomatology. Independent of a measure itself, 
significant indicators of depression can be found by querying the patient. Specifically, the 
physician may query the patient regarding depressed mood or hopelessness over the past 
2 weeks either concomitant with or independent of a loss of pleasure over the past 2 
weeks (Pignone, et al., 2002).  
Recently, the United States Preventive Services Task Force conducted an analysis 
of depression research studies, compiled the studies and expounded the pertinent 
research. Intervention was demonstrated to be better than a no-treatment control when 
depression is reassessed (Pignone, et al., 2002).  This task force deemed by this task force 
that to optimally benefit the patient, depression was best served when a physician 
assessed for symptoms and facilitated treatment because depression screening measures 
provide the physician or assessor with specific symptomatology.  Once elucidated, the 
specific symptomatology identified can assist the physician in ruling out a physiological 
cause of the depression symptoms (Pignone, et al., 2002).   
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 Beck Depression Inventory. To detect depression symptoms in a population with 
chronic pain depression symptomatology is most frequently assessed through a self-
report measure. The most commonly used self-report measure has been the Beck 
Depression Inventory (BDI) (Reynolds & Gould, 1981).  Used within various 
populations, including medically ill, psychiatric, and generally healthy populations, the 
BDI is a self-report measure consisting of 21 items, of which each correspond to a 
specific collection of cognitions and physical symptomatology  (Doering et al., 2007; 
Reynolds & Gould, 1981).  The BDI is a measure that is effective in measuring the 
intensity of depression symptomatology (Doering et al., 2007).   
Beck Depression Inventory-II.  The BDI-II is an updated version of the original 
BDI and gives a more accurate reflection of the depression criteria in the Diagnostic and 
Statistical Manual of Mental Disorders-IV-TR (DSM-IV-TR).  The BDI-II assesses for the 
concomitant existence of depression symptomatology, specifically the presence, and 
severity of depressive symptoms in the population with chronic pain (Poole et al., 2006).  
This measure is currently the principal tool used to diagnose depression.   
The BDI-II has been validated on adult and adolescent psychiatric patients, 
family-medicine patients, and other medical outpatients. In addition, the BDI-II has been 
validated on various populations with chronic pain such as those with neuropathic pain, 
neurovascular pain, and back pain (Poole et al., 2006). To date only a small sample of 
studies have been completed addressing the factor structure of the BDI-II in the 
population with chronic pain.   
Beck Depression Inventory--FastScreen. The BDI-FastScreen is a shortened 
version of the BDI-II. This measure, a derivative of the original BDI, was designed using 
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a combination of cognitive and affective symptoms of depression  (Beck, Steer, & 
Brown, 2000; Doering et al., 2007). Based on the most current edition of the DSM-IV-TR 
the BDI-II is the most prevalent measure used to identify depression. Using the BDI-II as 
a foundation, the BDI-FastScreen was developed as a rapid measure that would factor out 
neurovegetative signs of depression found in a medical population and concentrate on 
those factors of depression that relate soley to depression. This measure was specifically 
developed to factor out co-occurring depression symptomatology that may be related to a 
medical condition (Beck et al., 2000; Steer et al., 1999). Within the medical population, 
the BDI-FastScreen has been shown to differentially detect depression symptomatology 
(Beck et al., 2000; Steer et al., 1999).   
The directions for completing this measure request the informants to describe 
themselves ―Over the past two weeks, including today.‖  Items placed on this measure 
were chosen for their ability to reveal significant indications of risk.  The seven specific 
items on this measure include sadness, pessimism, past failure, loss of pleasure, self-
dislike, self-criticalness, and suicidal ideations  (Beck et al., 2000; Steer et al., 1999).  
This measure takes approximately 2 minutes to complete.  
The BDI-FastScreen utilizes 7 items to measure the cognitive and affective 
components of depression. The patient completing the measure rates each of these seven 
items on a 4-point scale ranging from 0 - 3, where a score of 3 indicates a significant 
amount of distress relating to that particular symptom. By summing the ratings on all 
seven items, one can compute a total score for the measure. The highest possible total 
score on this measure is 21 (Beck et al. 2000; Beck, Guth, Steer, & Ball, 1997).  
Depression, therefore, is significant at a much lower score when compared to the score on 
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the BDI-II (Doering et al., 2007).  For example, on the BDI-FastScreen, scores greater 
than 4 indicate a mild depression.   
Internal structure of the BDI-FastScreen.   When choosing the items to be 
placed on the BDI-FastScreen, Beck et al. (200) first identified required symptomatology 
per the DSM-IV-TR.  Looking at required symptoms, these authors identified the first 
two critical items namely, anhedonia and sadness.  According to the DSM-IV-TR, one of 
these two items is essential to the diagnosis of depression (Beck, Steer, & Brown, 2000). 
Given the imperativeness of identifying risk factors of suicide, suicidality is assessed in 
this measure as well and thus makes up the next factor.  The remaining items were 
identified and categorized from a factor analysis conducted with the BDI-II. A factor 
analysis was completed with a sample population of 620 people consisting of psychiatric 
patients and college students, although the latter comprised less than 20% of the sample 
population.  The four cognitive factors, pessimism, past failure, self-dislike and self-
criticalness, demonstrated significant factor loadings (> .35) when the BDI-II was 
developed (Beck et al., 2000).  Therefore, these four items constitute the cognitive 
domain of the measure and complete the seven items.  
The original study piloting the BDI-FastScreen elucidated a coefficient alpha of 
internal consistency at 0.86, thereby demonstrating good reliability (Beck et al., 1997). 
Beck extended his research on this measure to include medical samples from family 
practices, internal medicine practices, pediatric practices, and consultation liaison.  The 
coefficient alpha scores in these medical populations further demonstrated good 
reliability with scores ranging from .85 - .88 (Beck et al., 2000).   When Beck et.al. 
(1997), compared the BDI-FastScreen with another standardized measure of depression, 
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the BDI-FastScreen was positively related at 0.62, p < 0.001 thereby demonstrating 
notable convergent validity (Beck et al., 1997).  Finally, the BDI-FastScreen was a 
proficient instrument in identifying symptomatology consistent with depression.  
Therefore, on the basis of internal consistency, convergent validity and differential 
diagnosis, the BDI-FastScreen established itself as an effective measure in factoring out 
neurovegetive signs of depression found in the medical population and in illuminating the 
depressive symptomatology.  Beck, et. al. (1997) suggests progressive research utilizing 
this measure should concentrate on the utility of depression diagnosis within a diverse 
group of medical patients.  
 Prior research implementing the BDI-FastScreen. A paucity of studies has been 
conducted validating the effectiveness of utilizing the BDI-FastScreen within a 
population of patients with pain. Most of the research conducted with this measure has 
utilized a more general medical population, including inpatient and outpatient samples. 
For example, a group of researchers reviewed the effectiveness of the BDI-FastScreen 
within a population of HIV-infected patients.  These researchers found the BDI-
FastScreen to have good internal consistency, thereby demonstrating its effectiveness in 
identifying depression symptomatology in this population of HIV-infected individuals 
who also reported high levels of pain (Krefetz, Steer, Jermyn, & Condoluci, 2004).  In 
another study, the BDI-FastScreen was compared to Hospital Anxiety and Depression 
Scale (HADS) and the BDI-II in a population of patients with hepatitis C.  The results of 
this study indicate a Chronbach’s alpha score of.85 with this population was lower than 
the previously indicated .84 (Golden, Conroy, & O'Dwyer, 2007). Utilizing a Receiver 
Operating Characteristic (ROC) curve and examining the ability of the BDI-FastScreen to 
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accurately assess depression symptomatology was an additional area of validity assessed 
in this study.  This assessment measure identified .85, demonstrating the BDI-FastScreen 
was accurately able to distinguish the depression symptomatology (Golden et al., 2007).   
A third study used the BDI-FastScreen to assess for depression symptomatology in a 
geriatric group of stroke survivors (Healey, Kneebone, Carroll, & Anderson, 2008).  
Again, acceptable internal consistency was demonstrated in this study (Healey, 
Kneebone, Carroll, & Anderson, 2008).  These researchers also looked at the test-retest 
reliability and found positive results as well (Healey, Kneebone, Carroll, & Anderson, 
2008).   
 Researchers from the United Kingdom compared the BDI-II and the BDI- 
FastScreen within a group of patients with chronic pain in an attempt to demonstrate the 
usefulness of the BDI-FastScreen as it relates on a measure-to-measure consistency. The 
researchers found that eliminating some of the questions on the BDI-II decreased the 
chances of patients not answering a question or superficially inflating the scores (Poole, 
Bramwell, & Murphy, 2009).  The results indicate the BDI- FastScreen is a fair measure 
of depression within this population.  Although resulting in adequate internal consistency, 
the .84 is a lower internal consistency than was found by measure author, Beck.  These 
results could potentially be attributed to the low number of patients with pain included in 
the original study conducted by Beck.  The resulting data from this comparison indicate 
that the BDI-FastScreen is a more useful measure than the BDI-II and that the shorter 
measure serves to decrease the time burden on the patient (Poole et al., 2009).   
A recent study by Doering et al. (2007) demonstrated the effectiveness of the 
BDI-FastScreen when used to assess depression in women post cardiac surgery.  
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Resulting data from this study indicate the BDI-FastScreen is a useful tool to detect 
depression in this population. Most of the studies elucidated previously have incorporated 
adult populations; however, the effectiveness of screening for depression 
symptomatology within a population of adolescents has been demonstrated as well by 
Winter, Steer, Jones-Hicks, & Beck (1999).  Their research suggests the BDI-FastScreen 
can be utilized to assess for depression symptomatology in a normative sample of 
nonmedical adolescents aged 12-17 years.  
Sharpe and Lipsky (2002) noted that although the completion time on the BDI- 
FastScreen is minimal, the sensitivity of the measure may be affected.  However, the 
BDI-FastScreen has been shown to differentially diagnose depression within the medical 
population (Beck et al., 2000; Steer et al., 1999).  Specifically, in a 1999 study, Steer et 
al. demonstrated that the BDI-FastScreen with a score of 4 and above ascertained the 
highest clinical efficiency of 98%.   The corresponding specificity and sensitivity rates of 
98% and 97%, respectively, in signifying major depression disorder within a group of 
outpatients elucidates the effectiveness of the BDI-FastScreen, has in identifying 
depression symptomatology.  This study supported a previous internal consistency of 
0.85 (Steer et al., 1999).  
Detecting Depression in the Patient Sample 
In patients with chronic pain, depression has been established as the most 
common comorbid condition (Poole et al., 2006; Tennen et al., 2006).  Pain-clinic 
statistics report prevalence rates of depression ranging from 30% - 54% (Poole et al., 
2006).  In the population with chronic back pain, for example, depression is a common 
concomitant factor, with a prevalence rate as high as 52% (Wesley et al., 1999). A 
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psychological diagnosis, including depression symptomatology, often portends a less 
favorable prognosis for treatment of some medical disorders. Depression has been 
demonstrated to complicate the prognosis of chronic pain; yet, there are similarities in 
diagnostic criteria between depression and chronic pain (Poole et al., 2006). The 
connection between pain and depression is exemplified in areas of somatic function and 
negative views of self  (Tennen et al., 2006; Zlot et al., 2000).  Specific examples include 
somatic symptoms, such as sleep disturbances, and quality-of-life indicators, such as loss 
of interest in previously enjoyable activities. Research also has shown that depression 
influences pain and that pain can predict a depressive episode in individuals with a prior 
history of depression (Tennen et al., 2006). These reciprocal influences demonstrate an 
established connection between depression and chronic pain.    
The concomitant relationship between depression and chronic pain 
symptomatology has been well established (Poole et al., 2006; Tennen et al., 2006; 
Wesley et al.,1999).  The benefits of early intervention techniques targeting the 
depression also have been established (Dysvik et al., 2005). Identifying negative health 
habits, detrimental behavioral activities and possible distorted thinking that may 
accompany both depression and chronic pain symptomatology may then facilitate a better 
prognosis and minimize convalescence time. When assessing for depression, the 
physician must look at cognitive, affective, somatic, and behavioral components.  
Physicians’ Ratings of Depression 
Depression is a condition that is underdiagnosed by most physicians (Penn, 
Boland, McCartney, Kohn, & Mulvey, 1997). According to Ani et al. (2008), 
approximately two thirds of primary-care physicians have been found to demonstrate 
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difficulty in detecting depression.  Their 2008 study comparing physician ratings of 
depression and patient ratings of depression found that physicians underdiagnosed 
depression symptomatology.  In fact, they found that physicians detected only 31% of 
patients as depressed, though a depression measure more than doubled that number at 
75% (Ani, et al., 2008).  
When asked by Penn et al. (1997), physicians attributed the high rate of 
underdiagnoses of depression to their own uncertainty regarding specific depression 
nomenclature.  In addition to their perceptions regarding the ambiguity of the DSM or the 
International Statistical Classification of Diseases and Related Mental Health Problems 
(ICD) depression criteria, physicians also identified financial compensation subsequent to 
a psychiatric diagnosis as a concern. According to physicians’ self-reports, the 
underdiagnosis of depression primarily is the result of physicians’ uncertainty of 
depression criteria and fear of undercompensation (Penn et al., 1997).   
Results of a study with a sample population consisting of psychiatrists and 
primary-care physicians, including internal medicine doctors, indicate that physicians still 
demonstrate a lack of expertise when diagnosing major depressive disorder (Penn et 
al.,1997). According to World Health Organization statistics, primary care physician’s 
have been found to diagnose depression more often than other physician’s, identifying 
nearly 80% of the cases (Freeman et al., 2010). However, approximately half of the 
individuals diagnosed with depression do not meet the criteria outlined in the 
International Statistical Classification of Diseases and Related Mental Health Problems 
(ICD) (Freeman et al., 2010).  Missing the symptomatology of depression and 
consequently misdiagnosing or underdiagnosing an episode of major depression can 
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augment the mortality of this prevalent, but treatable, mood disorder (Penn et al., 1997). 
Depression is related to sensory, emotional and cognitive factors of pain. Assessing for 
depression at the outset of treatment and throughout the course of treatment may help 
clinicians to detect behavioral activities, distorted thinking and negative health habits that 
may assist them in understanding the patient in a comprehensive manner.  
Physicians’ Ratings of Pain 
Pain is frequently a co-occurring symptom or often an extension of a pre-existing 
medical disorder. When assessing a group of medical personnel regarding pain control in 
a population of patients with cancer, von Roenn et al. (1993) found 86% of the 
participants reported that patients’ pain levels were not being adequately treated.  
Physicians queried in this study reported approximately 48% of the patients they had 
contact with endured pain longer than 30 days.  Physicians rate poor pain assessment as 
the largest indicator of inadequate pain management (von Roenn, Cleeland, Gonin, 
Hatfield, & Pandya, 1993).  A study conducted with a group of physicians extrapolated a 
result demonstrating a patient’s low self-report of pain intensity or high self-reported pain 
intensity was not believed by his or her physician (Tait & Chiball, 1997).  If the physician 
discounts the patient’s perceived level of pain, the pain level may persist leaving the 
patient to contend with augmented pain levels.   
Tait and Chiball (1997) revealed that when patients reported high levels of pain, 
high pain intensity and significant emotional distress, medical personnel tended to 
disbelieve the patient self-report.  Specifically, the patient’s circumstances surrounding a 
pain episode and the patient’s relationships with the physician appeared to affect the 
physician’s appraisal of the present pain episode.  These results appeared to also be 
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similar also in nonmedical settings, as this same construct had been demonstrated within 
a group of nonmedically trained individuals. These individuals tended to disregard the 
described high level reported by individuals.  Physicians expressed more doubt when a 
patient reports elevated pain levels (Tait & Chiball, 1997).   
Physicians form opinions about their patient with pain by relying on aspects of the 
patient’s personality and the circumstances surrounding the appointment (Tait & Chiball, 
1997).  Prior research has demonstrated that some physicians may have preconceived 
expectations of the patients reported pain levels. According to Galer, Schwartz, and 
Turner (1997), patient’s self-report of pain relief is related to the physicians’ beliefs 
regarding pain reduction.  Physicians then, appear to be significant indicators of post 
procedure changes in pain levels.  In fact, physicians may subtly convey pain 
expectations to patients thereby suggesting to the patient the perceived pain outcome 
(Galer et al., 1997).  
 Previous research suggests that a clear medical reason for pain is more believable 
to the medical professional than pain presenting for an undetermined reason (Marquie et 
al., 2003; Tait & Chiball, 1997). When physicians from assorted disciplines are given a 
list of pain descriptors, all the physicians agree on which descriptors identify pain.  
However, there appears to be a discrepancy between the results within a population of 
patients experiencing an acute pain episode and those experiencing chronic pain (Tearnan 
& Dar, 1986).  Physicians report acute pain as negatively impacting a mood state, and 
activity level as being more painful than those individuals with more chronic 
symtomatology.  In fact, physicians report a positive attitude toward utilizing pain 
descriptors in terms of patients with acute pain, but not with patients with a more chronic 
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pain symptomatology (Tearnan & Dar, 1986).  When pain is the result of an identified 
cause, physicians interpret the pain with a higher degree of acumen than if the pain 
results from a more indistinguishable cause (Marquie et al., 2003). 
A study by Weisse, Sorum, & Dominguez (2003) examined the influence of race 
and gender on physicians’ pain-treatment choices.  Using common pain-related 
conditions, this study compared the gender of both physicians and patients while 
assessing pain-treatment choices. These researchers found that male physicians, as 
opposed to female physicians, prescribed more narcotic pain medication to both female 
and male patients. However, within the patient genders, male physicians were shown to 
prescribe lower doses of analgesic to female patients than to male patients. Conversely, 
female physicians, when compared to male physicians, gave lower doses of narcotic pain 
medication to male patients than to female patients. In this study, African American 
women were prescribed the lowest doses of pain medication (Weisse et al., 2003).   
The role of gender may play a part in identifying and appraising pain levels in an 
emergency-room setting. When a male physician identified the cause of a female 
patient’s pain, the physician interpreted the female patient’s pain to be lower than that of 
a male patient (Marquie et al., 2003). However, the opposite was true when the origin of 
the pain was indistinguishable. In this situation, a male physician interpreted a female 
patient to have a higher pain experience than that of a similar male when there was an 
identified cause for the pain episode (Marquie et al., 2003).  
In an emergency room setting, physicians rate patients’ pain lower than patients 
themselves rate the pain. Patients tend to report highest pain levels at the outset of the 
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relationship (Marquie et al., 2003).  Similarly, physicians also identify patients to have 
higher pain levels at the beginning of a course of treatment (Marquie et al., 2003). 
There also appears to be a discrepancy between male and female physicians and 
the manner in which each interpret pain episodes. When female physicians identified the 
cause of a female patient’s pain, that physician rated the pain the same for a male and 
female patient.  Conversely, when the origin of a female patients pain was not known, the 
female physician interpreted the pain level to be lower than the patient themselves 
interpreted the pain (Marquie et al., 2003).    
Pain Differences Across Cultures 
Various studies have demonstrated the difference of pain symptomatology across 
cultures. A study conducted by Green, Baker, Smith and Sato (2003 B) revealed specific 
differences when they compared African Americans’ self-reported pain levels to those of 
a Caucasian sample of patients with pain.  This study identified significantly elevated 
levels of pain, suffering, and loss of control for the African American sample.  Similar 
findings have been elucidated.  Comparatively, African Americans reported significantly 
more pain than that by their Caucasian counterparts (Green, Baker, Sato, L., & Smith, 
2003). Riley et al. (2002) also found that African Americans report higher levels of pain 
unpleasantness and pain behaviors. African Americans additionally tend to report more 
depressive symptoms (Green, Baker, Smith, et al., 2003; Riley et al., 2002).  A study by 
Green, Baker, Sato et al. (2003) revealed that African Americans reported more sleep 
disturbances, including initiating sleep and staying asleep, than did Caucasians.  This 
study also demonstrated that pain manifests differently in both groups as well.  Within 
the Caucasian, nonHispanic group, pain presented with more mood symptoms, such as 
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sadness and anhedonia than within the African American group. African Americans, 
conversely, reported mood symptoms of irritability and anxiety.  Overall, these results 
suggest that a pain experience is different among Caucasian, nonHispanic and African 
American patients with pain even when other factors are controlled for (Green, Baker, 
Sato et al., 2003).   
Psychosocial dimensions of pain also have been demonstrated to vary within 
different ethnic groups. Some studies have demonstrated that African Americans, when 
compared to Caucasians, reported more pain that interfered with activities of daily living 
(Cano, Mayo, & Ventimiglia, 2005; Ruehlman, Karoly, & Newton, 2005). In one specific 
study, these individuals also reported more pain-related disability when compared to their 
Caucasian counterparts (Cano et al., 2005).  Weisse et al. (2005) found that women and 
African American individuals reported higher pain levels than those reported by 
Caucasian men.  African Americans reported more unpleasantness depending on the 
gender of the experimenter.  Specifically, female experimenters generated more 
unpleasantness than that generated by male experimenters.  A discrepancy in pain reports 
depending on the ethnicity of the experimenter was also recorded.  Female subjects rated 
the task of identifying pain levels as more unpleasant when the experimenter was a male 
African American than when the experimenter was a male Caucasian.  The authors 
postulated that African Americans and women receive lower doses of pain medication; 
however, this group experienced increased pain intensity and unpleasantness (Weisse, 
Foster, & Fisher, 2005).   
Nguyen, Ugarte, Fuller, Haas, & Portenoy (2005) conducted a national cross-
sectional phone survey to ascertain the influence of ethnicity on access to pain 
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management treatments. They found that Hispanics were significantly less likely than 
African Americans or Caucasians to seek medical attention from their primary-care 
physician.  Of the 1,335 study participants, results demonstrated that African Americans 
(85%) and Caucasians (84%) would seek treatment 85% and 84% of the time 
respectively.  Hispanics, on the other hand, would only seek treatment only 70% of the 
time (Nguyen et al., 2005).   
Another study examined the utility of commonly used pain measures within a 
sample of ethnically diverse individuals (Fuentes, Hart-Johnson, & Green, 2007). 
Specifically, this study examined the usefulness of identifying pain with the following 
measures in two ethnic groups. The authors chose the McGill Pain Questionnaire, the 
Pain Disability Index, and the Brief Symptom Inventory to make the comparisons.  This 
study included African Americans and Caucasian participants who were examined in a 
chronic-pain clinic.  The results of the study demonstrated that African American 
individuals and individuals with a lower education did not complete all the McGill Pain 
Questionnaire items (Fuentes et al., 2007). Results of another study revealed that 
participants with higher levels of education report less pain and pain-related disability 
(Cano, Mayo, & Ventimiglia, 2005).  Education was viewed as a mediator of pain 
behaviors.  A study attempting to delineate if experimenter race and gender in addition to 
participant gender and race biased participant pain levels (Cano et al., 2005).  
Coping has been related to a patient’s perceived ability to deal effectively with 
pain (Cano et al., 2005).   Researchers have demonstrated that individuals with pain differ 
in coping strategies and that specific pain-coping strategies differ across cultures (Cano et 
al., 2005).   
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Most Efficacious Results 
 Researchers have long postulated that psychological factors affect the course and 
intensity of pain (Turk, Meichenbaum, & Genest, 1983). These factors not only impact 
the course of the disease but also possess the potential to affect patient appraisals of the 
disorder and the physiological underpinnings of the disorder as well (Turk et al., 1983). 
The most efficacious results of treating depression are obtained when the depression is 
identified and treated early (Campbell et al., 2003).  The most efficacious treatment of 
early-detected depression has been demonstrated to be psychotherapy (Freeman et al., 
2010).  In a study by Miranda et al. (2003) of an impoverished and culturally diverse 
sample of women, better psychosocial functioning was achieved when depression was 
detected early and treated with psychotherapy.  This concept was elaborated upon in a 
follow up study, again with a population of impoverished minority women (Miranda et 
al., 2006). Efficacious results were found when depression was treated with medications 
and CBT.   In fact, more than 50% of the women in the study were not clinically 
depressed at a 1-year follow-up as measured by a depression inventory (Miranda et al., 
2006).    
Statement of the Problem 
The concomitant relationship between depression and chronic-pain 
symptomatology has been well established  (Poole et al., 2006; Tennen et al., 2006; 
Wesley et al., 1999).  The benefits of early intervention techniques targeting the 
depression have also been established (Dysvik et al., 2005). Identifying negative health 
habits, such as drug or alcohol abuse or limited physical activity, detrimental behavioral 
activities such as smoking, and possible distorted thinking that may accompany both 
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depression and chronic-pain symptomatology may then facilitate a better prognosis and 
minimize convalescence time.  
There has been a lack of research regarding the factor structure and psychometric 
properties Beck Depression Inventory (BDI) in a population of patients with pain.  
Although the BDI is the most common measure administered to assess depression in the 
general medical population, there is a limited amount of research validating the 
psychometric properties of the BDI-FastScreen within the pain population.  Therefore, 
this study is purporting to identify the factor structure of the BDI-Fast Screen.   
Specifically, this study is attempting to correlate the factor structure of the BDI-
FastScreen to the factors on the encounter form and the physician appraisal of the patient.  
Data collected will additionally elucidate the relationship of patient and physician 
appraisal, demographic information, and the characteristics of the individual patient with 
pain, such as age, gender, diagnosis, onset and duration.   
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Chapter 3 
Hypotheses 
This study will examine the factor structure of the BDI-FastScreen within a 
sample of patients with pain and evaluate how this measure relates to patient and 
physician appraisal, demographic information, and characteristics of the individual 
patient with pain such as age, gender, diagnosis, onset and duration. 
Hypothesis 1 
There is a unique factor structure on the BDI-FastScreen for patients with pain.  It 
is expected, given the established concomitant relationship between pain and depression, 
that one overall cognitive item will emerge as the predominant feature.   
Justification. The BDI-FastScreen was developed to factor out neurovegetative 
signs of depression found in a medical population and concentrate on those factors of 
depression that relate soley to depression. This measure was specifically developed to 
factor out co-occurring depression symptomatology that may be related to a medical 
condition (Steer et al., 1999). Within the medical population, the BDI-FastScreen has 
been shown to differentially detect depression symptomatology (Steer et al., 1999). A 
factor analysis of the data will expound the observed data by demonstrating how each of 
the factors together elucidate the relationship between depression symptomatology found 
in patients with pain.  This statistical analysis will additionally explicate the character of 
the factor.  
Hypothesis 2 
Female patients with pain will have a significantly higher score on the BDI- 
FastScreen than that of male patients with pain at the outset of the pain evaluation.  
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Justification.  The lifetime prevalence rates of depression are different for adult 
men and women. A 1993 review of the National Comorbidity Survey revealed a lifetime 
prevalence rate of depression at 12% higher for women than men (Kessler et al., 1993). 
Women tend to have a higher lifetime prevalence rate further indicating increased rates of 
depression. Previous results have demonstrated lifetime prevalence rates of women with 
major depressive disorder are 17.1% (Kessler et al., 1993). 
Depression affects at least twice the number of women than men where women 
are diagnosed with depression more than twice the number of times men are diagnosed 
with the same disorder (Culbertson, 1997; Sloan & Sandt, 2006). Specifically, depression 
diagnoses for adult women are at 22.4% when compared to adult men with depression 
diagnoses of 13.9% (Angst et al., 2002). This difference appears to be relatively 
consistent across a wide range of cultures, with an average female-to male-ratio of 2:1 
(Immerman & Mackey, 2003). 
The role of gender appears to play a part in identifying and appraising pain levels. 
When a male physician identified the cause of a female patient’s pain, the physician 
interpreted the female’s pain to be lower than what he would rate the pain of a male 
patient (Marquie et al., 2003). However, the opposite was true when there was an 
indistinguishable pain origin. In this situation, a male physician interpreted a female 
patient to have a higher pain experience than that of a male patient experiencing a similar  
identified cause for the pain episode (Marquie et al., 2003). Women reported higher pain 
levels than those reported by Caucasian men  (Weisse, Foster, & Fisher, 2005). 
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Hypothesis 3 
A low positive correlation will be found between a physician’s rating of 
depression when assessed by a composite of depression-related items and a patient’s 
rating of depression using the BDI-FastScreen. Physicians who treat patients with pain 
were asked to appraise each patient’s level of depression upon completion of the patient’s 
visit. To understand the physician’s appraisals of patient depression, the physician was 
asked to answer the following questions at the end of the patient visit:  Did the patient 
appear depressed? Did the patient appear angry? Did the patient present with crying? 
Physician responses were given a numeric value 0 for a NO response and 1 for a YES 
response. The total score would be combined to total 0-3 points. 
Justification. A physician forms opinions about his or her patient with pain by 
relying on aspects of the patient’s personality and the circumstances surrounding the visit 
(Tait & Chiball, 1997). Prior research has elucidated the often prejudiced responses of 
physicians to patients’ self-reported pain levels. Patients’ self-reported pain relief is 
found to be related to physicians’ beliefs regarding pain reduction (Galer et al., 1997).  
Physicians, then, appear to be the more formidable indicators of postprocedure changes in 
pain levels (Galer et al., 1997). Physicians may subtly convey pain expectations to 
patients, thereby suggesting to the patient the perceived pain outcome.  
When patients report high levels of pain, high pain intensity, and significant 
emotional distress, medical personnel tend to disbelieve the patient self-report (Tait & 
Chiball, 1997).  Specifically, the patient’s circumstances during a pain episode and the 
patient’s relationship with the physician appear to affect the physician’s appraisal of the 
present pain episode (Tait & Chiball, 1997).  These appraisals appear to be similar in a 
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nonmedical setting also, as this same construct has been demonstrated within a group of 
nonmedically trained individuals. These individuals tend to disregard a patient’s self-
reported elevated of pain when individuals report elevated levels of pain. Physicians 
report more doubt when a patient reports elevated pain levels (Tait & Chiball, 1997).   
According to Ani et al. (2008) approximately two thirds of primary-care 
physicians fail to detect depression. Their study comparing physician ratings of 
depression and patient ratings of depression found physicians underdiagnosed depression 
symptomatology  (Ani, et al., 2008).  In fact, physicians detected only 31% of patients as 
depressed, though a depression measure more than doubled that number at 75%. 
Research has shown that, at times, physicians disregard high levels of pain as reported by 
their patients. At times, physicians often miss a diagnosis of a depressive episode. Taken 
together, these two concepts could impede the physicians’ the accurate assessment of a 
depressive episode.  
Hypothesis 4 
Gender will moderate the relationship between depression and pain. At low levels 
of depression, men and women will not differ in self-reported pain reports, whereas at 
high levels of depression, women will report significantly more pain than that reported by 
men. 
Justification. Research has been demonstrated that depression can manifest 
differently within genders. Women endorse symptomatology, such as depressed mood, 
crying, and guilt (Sloan & Sandt, 2006).  Men on the other hand typically report feelings 
of anger (Sloan & Sandt, 2006). The type and manifestation of depression 
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symptomatology has been demonstrated to be different between genders.  The prevalence 
of depression between genders is also different.   
 The lifetime prevalence rates of depression are different for adult men and 
women. A 1993 review of the National Comorbidity Survey revealed a lifetime 
prevalence rate of depression at 12% higher for women than men (Kessler et al., 1993). 
Women tend to have a higher lifetime prevalence rate further indicating increased rates of 
depression.  Women have a 17.1% lifetime prevalence rate of a major depression disorder 
(Kessler et al., 1993). 
Women are diagnosed with depression at more than twice the rate that men are 
diagnosed with the same disorder (Culbertson, 1997; Sloan & Sandt, 2006). Specifically, 
depression diagnoses for adult women are at 22.4% when compared to adult men with 
depression diagnoses of 13.9% (Angst et al., 2002). This difference appears to be 
relatively consistent across a wide range of cultures, with an average female-to male-ratio 
of 2:1 (Immerman & Mackey, 2003).  Although women receive doses of pain medication 
lower than those received by men, women experienced increased pain intensity and 
unpleasantness (Weisse et al., 2005).   
Hypothesis 5 
 A. Single-item, self-rated depression descriptors will be positively correlated with 
BDI-FastScreen total scores.  
B.  A linear combination of single-item, self-rated depression descriptors will 
significantly predict BDI-FastScreen total scores.  
 Justification. Previous research utilizing the BDI-FastScreen within a group of 
medical patients has demonstrated positive results. A group of researchers reviewed the 
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effectiveness of the BDI-FastScreen within a population of HIV-infected patients and 
found it to be effective in identifying depression symptomatology in this population of 
HIV-infected individuals who also reported high levels of pain (Krefetz et al., 2004). 
Using these efficacious results as a foundation, this study is attempting to advance the 
clinical utility of the BDI-FastScreen. This will be accomplished by further breaking 
down the seven items of the BDI-FastScreen into descriptors and embedding the 
descriptors into a different measure.  These corresponding one-word descriptors are 
expected to adequately assess depression. The BDI-FastScreen is designed to include a 
one-word descriptor followed by a sentence.  Each participant is asked to answer a 
question regarding the magnitude of the depression symptomatology. Questions were 
scored and ranged in magnitude from 0-3.  A score of 0 coincides with no reported 
symptom interference, a score of 1 denotes minimum symptom interference, a score of 2 
denotes moderate symptom interference, and a score of 3 denotes severe symptom 
interference.  
Hypothesis 6 
The factor structure of the modified SF-MPQ will comprise one or more pain 
factors and a distinctive depression factor.  
Justification. The self-administered SF-MPQ is used in both the clinical capacity 
and the research capacity and has an improved clinical utility (Grafton et al., 2005). The 
SF-MPQ was designed to adequately assess the affective and sensory modalities of pain 
that the patient is experiencing; however, there is no supportive research substantiating 
the factor structure (Grafton et al., 2005).  There have been however, studies supporting 
the criterion validity between the original MPQ and the SF-MPQ. Additionally, the SF-
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MPQ has demonstrated excellent reliability in the overall score as well as in the specific 
categories of sensory, affective, and average pain level.   
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Chapter 4 
Overview 
The purpose of this study was to determine the factor structure of the BDI-FastScreen 
and coefficient alpha reliability as this measure relates to a population of patients with 
pain. Rates of depression are higher in general medical patients with a concomitant high 
comorbidity of psychological disorders.  The reciprocal influences of pain and 
depression, such as negative emotions and a decrease in activity level, serve to perpetuate 
aspects of both disorders.  The BDI-FastScreen was developed to factor out 
neurovegetative signs of depression found in a medical population and concentrate on 
those factors of depression that relate soley to depression. This measure was specifically 
developed to factor out co-occurring depression symptomatology that may be related to a 
medical condition (Beck et al., 2000; Steer et al., 1999). 
Design and Design Justification  
In an attempt to achieve the previously stated goal of identifying a factor structure 
of the BDI-FastScreen, this study utilized existing data found in a large, multiphysician, 
multilocation pain-management practice. This retrospective study utilized a sample of 
individuals living in a large city in Pennsylvania, in the suburbs surrounding that urban 
setting, and in rural locations as well. The data were collected over a span of 1 month. 
Initially presented as a project developed to analyze quality of care, data were originally 
collected to assist in identifying ways to improve quality of patient care by ascertaining 
the times physicians underdiagnosed depression symptomatology. Although this measure 
was developed with the intention of being implemented within a diverse medical 
population, there is a dearth of research supporting the use of the BDI-FastScreen in a 
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population of patients with pain. Therefore, this design will hopefully lend support to the 
nature of the factor structure and psychometric properties of the BDI-FastScreen and 
thereby validate the use of this measure within a population of patients with pain.  
Participants 
The sample consisted of 328 male and female participants between the ages of 25 
and 96 years. There were 112 men and 152 women included in the study. The median age 
of the participants was 46 years, with a mean age of 57.90 years. The participants 
reported an average duration of pain symptoms lasting 10.39 months. Most participants 
did not identify pain as interfering with their daily activities or state that pain awakened 
them at night (M=1.88, SD=.71).  However, all participants were treated through 
pharmacological means.  The participants reported taking over-the-counter pain 
medications and or a combination of prescribed medications commonly used to treat 
pain.  
The sample was comprised of participants who represented a mixture of culture, 
gender, and ethnicities. Approximately 73% of the sample was Caucasian.  The next 
largest ethnic group, comprising 2.4 % of the sample, was Hispanic.  African Americans, 
(.9%), and Indians, (.3%) comprised the smallest, however homogeneous groups. A total 
of 3.7% of the sample participants either chose not to disclose their ethnicity or  were 
unable to provide particular data that could be gleaned from the patient-encounter 
measure.  
  According to the U.S. Census, approximately 808,210 individuals were living in 
2008 in the Allentown-Bethlehem-Easton area, otherwise known as the Lehigh Valley of 
Pennsylvania.  At the time of the 2008 census, the composition of the Lehigh Valley 
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revealed that male citizens comprised approximately 394,367 and female citizens 
comprised approximately 413,843 of the total population.  A majority of this population 
was Caucasians, 87.1%.  The remainder of the population was African American; 4.6%; 
Asian, 2.3%:  Hawaiian or Pacific Islander, 0.1%; different race, 4.3%; Hispanic and 
Latino, 11.3%.  The ethnic composition of the sample was similar to the composition of 
the 2008 reported ethnic composition thereby demonstrating an accurate appraisal of the 
population.  
The sample of the study included both new patients and those who were seen as 
follow-up patients. The following demographics were coded from the original 
demographic sheet:  age, gender, diagnosis, and onset. This information then was used as 
a basis of analysis for this present study.   
 As demonstrated in Table 1, the majority of the sample was comprised of 
individuals reporting low-back pain or lower extremity pain.  A total of 185 individuals 
reported some type of low-back pain and/or some pain derivative presenting in a lower 
extremity.  The second largest group, a homogeneous group, was comprised of 
individuals suffering from failed-back-syndrome.  Specifically, 65 participants reported 
having undergone a spinal surgery without receiving pain relief.  Forty-nine participants 
reported upper extremity pain, including neck or arm pain.  Eleven participants reported 
some type of pain derived from an orthopedic injury.  Approximately 17 participants 
reported a different avenue of pain.  This group included unspecified flank pain, pain 
from cerebral palsy, inguinal hernia pain, postthoractomy pain, or testicular pain.  
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Table 1 
Type of Pain Reported by Each Patient and the Corresponding Percentage of the Sample 
_______________________________________________________________________ 
 
Location of pain 
_____________________ 
Number of participants  
______________________ 
Percentage 
_______________________ 
Upper extremity, upper 
spine 
49 14.7 
Lower extremity, lower 
spine 
185 51.6 
Failed-back syndrome 65 19.8 
Orthopedic injury 11 3.3 
Other 17 5.1 
________________________________________________________________________ 
Note. The type of pain each participant reported.  
The demographic sheet contained information including patient gender, level of 
patient education, type of insurance, past behavioral health and medical history, and 
description of current pain episode.  Data obtained through this demographic packet 
assisted in further inclusion and exclusion criteria as follows.  
Inclusion and Exclusion Criteria  
This research study utilized archival retrospective data. At the time of data 
collection, participants were patients of a pain practice; therefore, each participant 
presented with varying degrees of persistent pain.  Each participant was required to read 
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English at the sixth-grade level. To be included in the study, participants had to be either 
new to the pain-management practice or established patients. All patients with chronic 
pain were diagnosed by one of the physicians in the group practice.  Participants with 
neuropathic pain associated with multiple sclerosis, myofasical pain, amputation, and 
postspinal surgeries were included in the study, were patients who reported neurological 
pain episodes, such as back pain, neck pain, and fibromyalgia. Participants with other 
forms of pain, such as rheumatoid arthritis and migraine were also incorporated into this 
study.   
For the purpose of this study, all patients entering the practice who sought care for 
pain were included in the study. The requirements to be seen at this pain clinic included 
an age restriction of 18 years or older, and thus the only exclusion criterion noted was for 
pediatric or adolescent care (i.e. any person under the age of 18). All new patients 
entering the practice during the period of data collection were eligible for the study.  
Current patients being examined for follow-up reasons were also included in the data set.   
Recruitment 
Data for this research project are archival, and no recruitment was needed for the 
present analysis to be completed.   
Informed Consent  
Originally developed as a project analyzing quality of care, data were collected to 
assist in identifying ways to improve quality of patient care by ascertaining the times 
physicians underdiagnosed depression symptomatology. By choosing to seek care from 
one of the pain-management physicians, patients assented to treatment and quality-of-
care information was obtained at the outset of their allotted appointment time.  
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Measures 
 BDI-FastScreen. The current study used the BDI-Fast Screen to identify the 
manner in which depression symptomatology scored, within a sample of patients with 
pain.  The original study piloting the BDI-FastScreen elucidated a coefficient alpha of 
internal consistency at 0.86, thereby demonstrating good reliability (Beck et al., 1997; 
Beck et al., 2000). When Beck et al. (1997; 2000) compared the BDI--FastScreen with 
another standardized measure of depression, the BDI-FastScreen was positively related at 
0.62, p< 0.001, thereby demonstrating notable convergent validity (Beck et al., 1997; 
Beck et al., 2000). Finally, the BDI-FastScreen was further demonstrated to be a 
proficient instrument in identifying symptomatology consistent with depression.  
Therefore, on the basis of internal consistency, convergent validity, and differential 
diagnosis, the BDI-FastScreen established itself as an effective measure in factoring out 
neurovegetative signs of depression found in a medical population and in illuminating the 
depressive symptomatology.  Beck et al. (2000) suggested that progressive research 
utilizing this measure should concentrate on its utility in depression diagnosis within a 
diverse group of medical patients.  
Patient encounter form. This form contains demographic information including 
age, gender, location of pain, and diagnosis.  This form was used also to assess for a 
range of pain and depression dimensions in each of the participants.  Specifically, 
participants were asked to rate factors associated with pain on a scale of 1-4, 1 being the 
least amount of interference and 4 being the most amount of interference. Patients were 
additionally asked to rate their overall pain level on a Likert Scale of 0-10, 0 being no 
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pain and 10 being the most pain imaginable.  Participants were additionally asked to 
identify if their present pain level interfered with sleep.  
Physician Appraisals. Subsequent to performing their examination, physicians 
were requested to answer the following questions: Did the patient appear depressed? Did 
the patient appear anxious? Did the patient express anger? Physicians provided a yes or 
no response to each question. 
Procedures 
To complete this project, permission was obtained from the physician responsible for 
the original data collection, including originating the initial research question. De-
identified data were received from the pain-research team leader for the purpose of 
completing this study.  
When data collection was conducted, each participant was requested to complete a 
BDI-FastScreen.  The completed measure was reviewed and scored by a doctoral-level 
psychologist.  Each participant was additionally requested to complete an encounter form 
developed by the pain practice. Data analysis for this research study did not produce any 
risk for the participants.  The data collected were archival and no new data were collected 
to complete the analysis. There was no inherent risk to the participants as this was a 
retrospective study. 
The data set used for this dissertation was originally collected in 2003 in a 
population of patients with pain.  This archival data set asked basic questions pertaining 
to the comorbid depression symptomatology that one pain-management physician found 
recognizable. This study was designed to provide physicians with diverse insights about 
the ability to utilize multiple depression measures to provide treatments for their patients. 
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The concomitant relationship between depression and pain symptomatology has been 
well established (Poole et al., 2006;Tennen et al., 2006; Wesley et al., 1999). The benefits 
of early intervention techniques targeting the depression have also been established 
(Dysvik et al., 2005). Identifying negative health habits, detrimental behavioral activities, 
and possible distorted thinking that may accompany both depression and pain 
symptomatology may facilitate a better prognosis and minimize convalescence time. 
Therefore, an integrated patient profile targeting depression and pain will enhance 
diagnostic abilities and afford the patient the benefit of early depression detection.  In the 
context of routine pain-management treatment, if physicians in a multidisciplinary pain 
practice can promptly and accurately detect and identify patients with a comorbid 
depression episode, the current pain episode could potentially be minimized.  Therefore, 
the current study did not produce any risk to the participants.  However, it will 
complement existing research on early depression identification within a population of 
patients with pain.  
Maintaining Confidentiality 
For the purpose of this research study, there is no access to the original data.  The 
data set provided for the purpose of this study contained de-identified information. The 
information provided releases only for identifying information such as age and gender.  
In and of itself, this information does not violate confidentiality, and therefore, there is no 
possibility of identifying participants and hence, nothing to safeguard.  Given the wide 
demographic location and large number of patients this practice averages, this 
information would not violate any rules of confidentiality.   
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Chapter 5 
Results  
 Statistical analyses were conducted to address each hypothesis.  Basic data, such 
as the specific demographic characteristics of the sample, were compiled and will be 
reported.  Information such as mean pain ratings, including the manner in which each 
participant characterized his or her pain, will be addressed and elucidated. Medications 
reported by each participant were extracted as well. Owing to the limited research on the 
BDI-FastScreen within a sample of participants with chronic pain, some initial 
descriptive statistical analyses were conducted and will be reported.  Results pertaining to 
the internal consistency of the BDI-FastScreen were examined to ensure the reliability of 
the measure. The factor structure of the BDI-FastScreen as it relates to a population of 
chronic-pain sufferers was also examined.  Gender was investigated as a moderator of 
depression and pain. Physician identification of depression as compared to self -reported 
depression symptomatology was also examined.  Finally, the factor structure of the 
modified SF-MPQ was examined.  
 Demographic characteristics of the sample. The participants with chronic pain 
identified pain duration from 0-120 months (m= 10.39 months; SD = 16.62 months).  Of 
the 328 participants, 222 participants described their pain as a 6 or above on a scale of 1-
10. On this scale, a pain score of 1 was equal to the least amount of pain the participant 
had ever experienced, and a pain score of 10 was equal to the greatest amount of pain the 
participant had ever experienced. A total of 106 participants rated their pain as a 5 or 
lower on the same pain scale of 1-10.  The mean pain score, as rated by the patients, was 
5.5  (SD = 2.78).  Within this population, the modal pain rating was a 5.  Eighteen percent 
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of the study participants described their pain level as a 5. Seven (7) was the second-most 
designated pain rating and was chosen by 14.6 % of the participants. The third-most 
frequently chosen pain rating was an 8, which was rated by 10.1 % of the participants.  
Slightly more than 67% of the study participants identified a high pain level, thus 
indicating that more than two thirds of the participants were experiencing significant pain 
levels. Contrary to the reported high pain levels, most participants did not identify pain as 
interfering with daily activities or interrupting sleep at night.  
All participants did report that they were employing pharmacological treatments 
to control the pain.  The participants reported taking a range of medications to assist with 
pain assuagement. For example, patients reported taking over-the-counter pain 
medications such as ibuprofen, naprosyn or acetaminophen to control their pain levels. 
The participants also reported a wide range of prescription-strength nonsteroidal anti-
inflammatory drugs, such as rofecoxib, valdecoxib, tolmetin and diclofenac.  The 
participants also reported taking muscle relaxants, such as metaxalone, baclofen and 
tizanidine. Steroids, injectable and oral, such as triamcinolone, methylprednisolone, and 
prednisone types, were reported. Participants additionally reported taking opiod-based 
medications, such as propoxyphene, hydrocodone, oxycodone, and morphine, as pain 
relievers.  Other pain relievers, such as transdermal patches, benzodiazepines and 
anticonvulsants, were further categories of pain-controlling medications.  Finally, 
antidepressants, including tricyclics, select serotonin reuptake inhibitors (SSRIs) and 
serotonin antagonists, were reported as well.   
Psychometric characteristics of BDI-FastScreen. The items on the BDI-
FastScreen tended to be moderately correlated.  As demonstrated in Table 2, the 
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correlations ranged from .25 to .58. The items most highly correlated were pessimism and 
loss of pleasure (r=.58).  The lowest correlating items were suicidal thoughts and past 
failure  (r=.25).  Cronbach’s alpha for the BDI-FastScreen, standardized items, was .82. 
This score suggests that the BDI-FastScreen items, as used within a sample of patients 
with pain possess a relatively high internal consistency.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
63 
 
Table 2 
InterItem Correlation Matrix of the Individual Items of the BDI-FastScreen 
________________________________________________________________________ 
BDI-
FastScreen 
Item  
___________ 
Sadness 
 
 
_______  
Pessimism 
 
 
________ 
Past 
Failure 
 
______ 
Loss of 
Pleasure 
 
_______ 
Self-
Dislike 
 
______ 
Self-
Critical 
 
______ 
Suicidal 
Thoughts 
 
_______  
Pessimism .561       
Past 
Failure 
.320 .307      
Loss of 
Pleasure 
.447 .575 .329     
Self-
Dislike 
.499 .416 .420 .473    
Self-
Critical 
.408 .343 .479 .350 .540   
Suicidal 
Thoughts 
.418 .381 .254 .266 .350 .337  
________________________________________________________________________ 
Note.  All were statistically significant 
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When the patients were asked to rate the intensity of their pain during the past 2 
weeks, the most highly rated items, in order of descending intensity, included ―aching,‖ 
―sharp,‖ ―frustrating,‖ ―non-pleasurable,‖ and ―tiring/exhausting‖.  Three of the top five 
descriptors are not physical descriptions of pain. Rather, these top three are categorized 
as emotional aspects of pain. The overall mean of patient pain descriptors is 19.74. Table 
3 lists all the pain descriptors with their individual means and standard deviations.  
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Table 3 
Patient Pain Descriptor Ratings with Means and Standard Deviations in Descending 
Order of Rated Intensity  
________________________________________________________________________ 
Pain Descriptors 
 
________________ 
N 
 
________________ 
Mean 
Rating 
________________ 
Standard Deviation  
Rating 
________________ 
Aching 328 1.85 1.09 
Sharp 328 1.54 1.12 
Frustrating 328 1.41 1.16 
Nonpleasurable 328 1.40 1.21 
Tiring/Exhausting 328 1.37 1.25 
Shooting 328 1.29 1.19 
Throbbing 328 1.19 1.14 
Discouraging  328 1.12 1.15 
Stabbing 328 1.12 1.21 
Tender 328 1.09 1.15 
Gnawing 328 .80 1.08 
Hot/Burning 328 .77 1.05 
Cramping 328 .75 1.04 
Maddening 328 .74 1.032 
Sickening 328 .64 .99 
Punishing/Cruel 328 .59 1.01  
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Saddening 328 .54 .92 
Fearful 328 .51 .93 
Splitting 328 .49 .92 
Failure 328 .34 .77 
Life-ending 328 .19 .60 
 
________________________________________________________________________ 
 
Note. Pain descriptors are those found on the encounter form.  Patients were asked to rate 
their present pain experience on a scale of 0-3. A score of 0 was equal to ―none‖, a score 
of 1 was equal to ―mild‖, a score of 2 was equal to ―moderate,‖ and a score of 3 was 
equal to ―severe.‖  Means and standard deviations of the ratings are denoted as well.  
 
 
 
 
Table 4 reports the depression descriptors, as found on the BDI-FastScreen, with 
the corresponding means and standard deviations. Patients were asked to read various 
statements and choose a statement which best described him or her. Each question was 
scored and ranged in magnitude from 0-3.  A score of 0 coincided with no reported 
symptom interference, a score of 1 denoted minimum symptom interference, a score of 2 
denoted moderate symptom interference, and a score of 3 denoted severe symptom 
interference. Means and standard deviations were derived from patient total score of each 
question.  
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Table 4 
Descriptive Statistics on Items of the Patient BDI-FastScreen 
________________________________________________________________________ 
BDI-FastScreen 
  
Descriptor  
________________ 
N 
 
 
________________ 
Mean 
 
Rating  
________________ 
Standard Deviation  
 
Rating  
________________ 
Sadness 328 .35 .64 
Pessimism 328 .49 .70 
Past Failure 328 .21 .54 
Loss of Pleasure 328 .77 .81 
Self-Dislike 328 .35 .66 
Self-Criticalness 328 .34 .63 
Suicidal Thoughts 328 .06 .26 
________________________________________________________________________ 
Note. Depression descriptors as found on the BDI-FastScreen.  Patients were asked to 
read various statements and choose which statement best described them. Questions were 
scored and ranged in magnitude from 0-3.  A score of 0 coincided with no reported 
symptom interference, a score of 1 denoted minimum symptom interference, a score of 2 
denoted moderate symptom interference, and a score of 3 denoted severe symptom 
interference.  
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Factor structure of the BDI-FastScreen.  To examine the factor structure of the 
BDI-FastScreen, a principal components analysis using varimax rotation was conducted. 
The seven items of the instrument were subjected to an exploratory factor analysis with 
varimax rotation using Kaiser’s criterion of eigenvalues equal to 1 to determine 
components.  The varimax rotation method was used because the depression factors were 
not expected to be correlated. Using eigenvalues of 1 or higher, results demonstrated that 
within this sample of patients with paim, only one factor emerged, which accounted for 
49.18% of the variance.  As elucidated in the Table 5, interpretation of the latent factor 
suggests a factor most consistent with dysphoria within this sample of patients with pain.   
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Table 5 
Principal Components Analysis. Results for the Latent Variable 
________________________________________________________________________ 
BDI-FastScreen Items in Patients with Pain 
___________________________________ 
Component  1 
__________________________________ 
Sadness .757 
Pessimism .741 
Past Failure .619 
Loss of Pleasure .710 
Self-Dislike .765 
Self-Criticalness .705 
Suicidal Thoughts .594 
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Gender differences in depression.  Hypothesis 2 was evaluated by conducting a 
two-factor ANOVA.  A two-factor ANOVA (gender: male vs. female, and pain: (median 
split of high vs. low self-rated pain level) was performed to test for gender differences in 
depression, pain level differences in depression, and the interaction of gender and pain on 
depression. The Levene’s test for equality of error variances was not significant,         
F(3, 260)=1.279, p = .282). In this sample of patients with pain, women were not more 
depressed than men. No significant effect was found for gender, F(1,260) = 3.046, p =.08 
but the difference approached significance. For the dichotomized category of depression 
on the BDI-FastScreen (comparing no depression vs. depression) no significant main 
effect was observed, F(1, 260) = 3.673, p =.056; however, the difference once again 
approached significance. The interaction effect was also nonsignificant, F(1, 260) = .011, 
p = .917). Based on a power analysis using a G power method, the observed power for 
these three analyses was low at .412, .480, and .051 respectively.  The ANOVA summary 
is provided in Table 6.  The means for gender categorized by depression level are shown 
in Table 7.   
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Table 6 
ANOVA Summary 
Dependent Variable: Present Pain ANOVA Summary Table 
________________________________________________________________________ 
Gender     
________________ 
Mean 
________________ 
Std. Deviation  
________________ 
                           N 
_________________ 
Men                    0 
1 
Total  
 
5.20 
5.87 
5.38 
 
2.70 
2.69 
2.69 
 
81 
31 
112 
 
Women              0 
1 
Total  
 
5.81 
6.56 
6.02 
 
2.80 
2.31 
2.68 
 
109 
43 
152 
 
Total                   0 
1 
Total  
 
5.55 
6.27 
5.75 
 
2.76 
2.47 
2.70 
 
190 
74 
264 
 
________________________________________________________________________ 
Note. A two factor ANOVA to test for gender differences in depression, pain 
level differences in depression, and the interaction of gender and pain on depression. 
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Table 7 
Means for Gender Categorized by Depression Level 
________________________________________________________________________ 
Source 
 
 
________ 
Type III 
Sum of 
Squares  
________ 
df 
 
 
________ 
MS 
 
 
________ 
F 
 
 
________ 
Sig 
 
 
________ 
Partial Eta 
Squared  
 
_________ 
Corrected 
Model 
53.62 3 17.87 2.50 .061 .028 
Intercept 7128.70 1 7128.70 994.41 .000 .793 
Gender 21.64 1 21.84 3.05 .082 .012 
Bfsdichot 26.33 1 26.33 3.67 .056 .014 
Gender X 
bfsdicot 
.078 1 .078 .011 .917 .000 
Error 1863.88 260 7.17    
Total  10646.00 264     
Corrected 
Total  
1917.50 263     
________________________________________________________________________ 
Note. A two-factor ANOVA (gender: male vs. female: and pain: (median split of high vs. 
low self-rated pain level) was performed to test for gender differences in depression, pain 
level differences in depression, and the interaction of gender and pain on depression. No 
significant effect was found for gender, the dichotomized category of depression on the 
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BDI-FastScreen (comparing no depression vs. depression) or the interaction effect; 
however, the differences approached significance.   
Patients’ versus physicians’ appraisal of depression.  Hypothesis 3 was 
evaluated by conducting a Pearson’s correlation to test the association between variables. 
Results were expected to indicate that a low positive correlation would be found between 
physicians’ ratings of depression, when assessed by a composite of depression-related 
items, and patients’ ratings of depression using the BDI-FastScreen. Physicians were 
asked to appraise each patient’s level of depression upon completion of the patient visit. 
To understand physicians’ appraisals of patient depression, physicians were asked to 
answer the following questions at the end of each patient visit:  Did the patient appear 
depressed? Did the patient appear angry? Did the patient present with crying? Physician 
responses were given a numeric value of 0 for a NO response and 1 for a YES response. 
The score was combined and totaled, resulting in a possible overall total ranging from 0-3 
points. Each participant was asked to complete a BDI-FastScreen depression measure.  
The total score on the patient’s completed BDI-FastScreen was the corresponding patient 
depression rating.  
A significant correlation between the physicians’ rated depression score and the 
patients’ corresponding self-reported depression scores on the BDI-FastScreen (r = .349, 
p. < .001) was found. The coefficient of determination reveals that the physicians’ pain 
composite accounted for 12.18% of the variability in BDI-FastScreen scores. 
Gender as a moderator between depression and pain.  A 2 (male vs. female) X 
3 (level of depression: minimal, mild, and moderate depression) univariate ANOVA was 
used to test hypothesis 4; that there would be an interaction of gender and level of 
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participant depression on pain ratings. At low levels of depression, results predicted that 
men and women would not differ in self-reported pain whereas at high levels of 
depression, women were expected to report significantly more pain than that reported by 
men. Levene’s test of equality of error variances was not significant, F(92, 258) = 1.794, 
p =.114. The ANOVA results demonstrate that the main effect of gender, F (1, 258) = 
.430, p = .513 was not significant. However, the effect of level of depression on pain was 
significant, F (2, 258) = 5.593, p =.004. Using a post hoc Tukey, patients in group 0 
(minimal depression) had significantly lower ratings of pain than those in group 2 
(moderate depression), and those in group 1 (mild depression) had significantly lower 
pain levels than those in group 2 (moderate depression). In addition, the interaction 
between gender and depression level was not significant F (2, 258) = .430, p = .651. 
Table 8 reports the Levene’s equality of error variance and Table 9 reports main effect 
for gender and the effect of level of depression on pain gender.   
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Table 8 
ANOVA Demonstrating Gender as Moderator Between Depression and Pain 
_______________________________________________________________________  
Gender         BF 
________________ 
Mean 
________________ 
Std. Deviation 
_________________ 
N 
________________ 
Total                   0 
1 
2 
Total  
 
5.55 
5.86 
7.87 
5.75 
 
2.76 
2.46 
1.85 
2.70 
 
190 
59 
15 
264 
 
________________________________________________________________________ 
 Note. 2 X 3 ANOVA was completed to test the hypothesis that there would be an 
interaction of gender and level of participant depression on pain ratings. Levene’s test of 
equality of error variances was not significant.  
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Table 9 
ANOVA Demonstrating Gender as Moderator Between Depression and Pain 
________________________________________________________________________  
Source 
 
 
________ 
Type III 
Sum of 
Squares  
________ 
df 
 
 
________ 
MS 
 
________ 
F 
 
 
________ 
Sig 
 
 
________ 
Partial Eta 
Squared  
 
_________ 
Corrected 
Model 
106.82 5 21.36 3.04 .011 .056 
Intercept 4004.02 1 4004.02 570.52 .000 .690 
Gender 3.02 1 3.02 .43 .513 .00 
Level of    
depression 
78.50 2 39.25 5.59 .004 .042 
Gender X 
Level of 
depression  
6.04 2 3.02 .430 .651 .003 
Error 1810.69 258 7.02    
Total  10646.00 264     
Corrected 
Total  
1917.50 263     
________________________________________________________________________ 
Note. The main effect for gender was not significant; however, the effect of level of 
depression on pain was significant.  
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Single-item self-rated depression descriptors.  A correlation matrix was 
produced to test hypothesis 5; single-item self-rated, depression descriptors will be 
positively correlated with BDI-FastScreen total scores. Table10 identifies the full range 
of correlations.   
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Table 10 
Patient Self-Rated Depression Descriptors in a One-Tailed Distribution   
________________________________________________________________________ 
BDI-FS Total 
 
 
  
__________ 
BDI-FS 
Total 
__________ 
Saddening 
 
___________ 
Discouraging 
 
___________ 
Frustrating  
 
_________ 
Maddening  
 
__________ 
BDI-FS Total  
Pearson’s  
 
1.00 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Saddening 
 Pearson’s 
 
.405
**
 
 
 
 
1.00 
 
 
 
 
 
 
 
 
 
 
 
 
Discouraging 
Pearson’s 
 
 
 
.381
**
 
 
 
 
.578
**
 
 
 
 
1.00 
 
 
 
 
 
 
 
 
 
Frustrating 
Pearson’s 
 
 
.324
**
 
 
 
.507
**
 
 
 
.671
**
 
 
 
 
1.00 
 
 
 
 
 
Maddening 
Pearson’s 
 
 
.362
**
 
 
 
.523
**
 
 
 
 
.630
**
 
 
 
.609
**
 
 
 
1.00 
 
 
Life-ending 
Pearson’s 
 
 
.380
**
 
 
 
.412
**
 
 
 
.377
**
 
 
 
 
.316
**
 
 
 
.482
**
 
 
Non 
Pleasurable  
Pearson’s 
 
 
 
.313
**
 
 
 
 
.450
**
 
 
 
 
.628
**
 
 
 
 
.618
**
 
 
 
 
.544
**
 
Failure 
Pearson’s  
 
.399
**
 
 
.400
**
 
 
.448
**
 
 
.375
**
 
 
.471
**
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 Life-Ending 
_________________ 
Non-Pleasurable 
________________ 
Failure 
________________ 
BDI-FS Total  
Pearson’s 
 
.380
**
 
 
.313
**
 
 
.399
**
 
Saddening 
 
 Pearson’s 
 
 
 
.412
**
 
 
 
.450
**
 
 
 
.400
**
 
Discouraging 
 
Pearson’s 
 
 
 
.377
**
 
 
 
 
.628
**
 
 
 
 
.448
**
 
 
Frustrating 
 
Pearson’s 
 
 
 
.316
**
 
 
 
.618
**
 
 
 
.375
**
 
Maddening 
 
Pearson’s 
 
 
 
.482
**
 
 
 
 
.544
**
 
 
 
 
.471
**
 
 
Life-ending 
 
Pearson’s 
 
 
1.00 
 
 
 
.318
**
 
 
 
 
 
NonPleasurable  
 
Pearson’s 
 
 
 
.318
**
 
 
 
1.00 
 
 
 
 
Failure 
 
Pearson’s 
 
 
 
.507
**
 
 
 
 
.396
**
 
 
 
1.00 
 
________________________________________________________________________ 
Note. Data were collected on 328 participants and a one tailed test was used to evaluate 
the correlation between self-rated items and depression descriptors. As demonstrated in 
the above tables, the manner in which all the patients self-rated the specified depression 
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descriptors resulted in a significant correlation between the BDI-FastScreen scores and 
the items on the patient encounter form. All the correlations found were significant at the 
0.01 level.  
A linear combination of single-item, self-rated depression descriptors as 
predictors. To further investigate the relationship between self-rated depression 
descriptors and BDI-FastScreen total scores, multiple regressions analyses were 
conducted. The overall regression equation was significant, F (7, 320) = 16.267, p< 
.001).  Overall, the self-rated measures of depression were significant indicators of the 
BDI-FastScreen total scores. A linear regression analysis revealed that three self-rated 
depression descriptors, saddening (b = .60), life-ending (b=.78) and failure (b = .70), 
were highly significant predictors of BDI-FastScreen total scores.  Overall, the 
combination of the self-rated descriptors saddening, life-ending, and failure significantly 
predicted the BDI-FastScreen total F (7, 320) = 16.27, p. = .000) and thereby 
demonstrated that the results found were better than chance.  Table 11 provides a 
summary of the regression coefficients and Table 12 delineates the combination of self-
rated descriptors as predictors.   
 
 
 
 
 
 
 
81 
 
 
 
Table 11 
Regression Coefficients Demonstrating the Relationship Between Self-Rated Depression 
Descriptors and BDI-FastScreen Total Scores 
________________________________________________________________________ 
Parameter  
 
__________ 
Sum of 
Squares 
__________ 
df 
 
__________ 
MS 
 
__________ 
F 
 
__________ 
Sig 
 
__________ 
Regression 788.49 7 112.64 16.27 .000 
Residual 2215.9 320 6.925   
Total  3004.39 327    
Note. Regression Coefficients. The overall regression equation was significant. 
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Table 12 
The Combination of Self-Rated Items as Predictors of BDI-FastScreen Scores  
___________________________________________________________________ 
 Unstandardized                           Standardized  
   Coefficients                               Coefficients 
__________________________________________________________________ 
Model 
_________ 
B 
__________ 
SE 
__________ 
Beta 
__________ 
t 
_________ 
Sig 
___________ 
Constant 1.36 .243  5.57 .000 
Saddening .60 .207 .181 2.87 .004 
Discouraging .241 .202 .091 1.19 .234 
Frustrating .065 .187 .025 .349 .727 
Maddening .065 .208 .022 .315 .753 
Life-Ending .779 .301 .154 2.57 .010 
Nonpleasurable .069 .167 .028 .414 .679 
Failure .701 .237 .177 2.95 .003 
________________________________________________________________________ 
Note. The combination of the self-rated descriptors saddening, life-ending, and failure 
significantly predicted the BDI-FastScreen total. 
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Factor structure of the modified SF-MPQ. The factor structure of the modified 
SF-MPQ comprised three depression factors and one distinctive pain factor.  To examine 
the factor structure of the modified SF-MPQ a principal components factor analysis using 
varimax rotation was conducted. The 22 items of the instrument were subjected to an 
exploratory factor analysis by varimax rotation with Kaiser’s criterion of eigen values 
greater than 1.  The examination of the resulting scree plot from the factor analysis 
suggested a three-factor solution. Item loadings at .40 and above were considered 
significant.  A fourth factor was made up of only one item and was discarded.  
Factor 1 consists of life-ending, fearful, punishing, heavy, splitting, and sickening 
and seemed to reveal a latent factor labeled as Burdensome.  Factor 2, referred to as 
Discouragement, is made up of frustrating, discouraging, tiring/exhausting, tender, 
aching and gnawing.  Factor 3, is comprised of shooting, stabbing, sharp and throbbing.  
Factor 3 was referred to as the Quality of Pain.   
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Table 13 
Items from the modified SF-MPQ Depicting the Factor Loadings of the 22 Items  
      Components  
________________________________________________________________________ 
Descriptor 
_______________ 
1 
____________ 
2 
____________ 
3 
____________ 
4 
____________ 
Throbbing .386 .190 .500 -.175 
Saddening  .455 .403 .246 .219 
Shooting .144 .191 .765 .163 
Discouraging  .367 .712 .152 .190 
Stabbing .182 .151 .782 .216 
Frustrating  .241 .756 .233 .192 
Sharp .100 .247 .775 .055 
Maddening  .561 .513 .163 .167 
Cramping  .320 .264 .201 .366 
Life-ending  .752 .077 .046 .266 
Gnawing  .340 .576 .040 .081 
Nonpleasurable  .205 .688 .271 .262 
Hot/Burning  .162 .229 .303 .558 
Failure  .682 .226 .099 .098 
Aching  .174 .604 .282 -4.28 
Heavy  .535 .299 .363 -.321 
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Tender .218 .599 .310 -.073 
Splitting  .552 .271 .353 -.025 
Tiring/Exhausting .291 .688 -.176 .003 
Sickening  .703 .358 -.163 -.002 
Fearful .738 .318 .133 .027 
Punishing/Cruel  .661 .294 .240 .029 
________________________________________________________________________ 
Note. Item loadings at .40 and above were considered significant. 
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Chapter 6 
Discussion 
Chronic pain is a monumental public health issue. This study proposes that the 
multidimensionality and physiologic make-up of pain may amplify depression symptoms 
and may additionally impact the intensity of the pain. Psychological sequelae are often 
found comorbid with a pain diagnosis and will affect an individual in a physiological, 
sociocultural, and affective manner. Depression is a specific concomitant condition often 
found within the population of patients with pain. Depression will exacerbate medical 
symptoms, thereby negatively affecting social adjustment and future recovery (Clark et 
al., 1998).  In all patients with pain the individual’s ability to appropriately function is 
negatively impacted and disabilities often ensue. Pain-related disability, coupled with 
medical costs, is estimated to reach about $70 billion dollars annually (Gatchel, 2001). 
This study identified specific psychometric qualities of the BDI-FastScreen within a 
population of patients with pain beginning with a proposed factor structure and ending 
with an integrated model allowing for expedited depression detection. The ease of 
detecting depression in this medical population within the context of one measure is a 
benefit. Given the high concomitant relationship between depression and pain, assessing 
for this disorder is imperative. Depression is often found to be more prevalent in women 
than in men and further complicates a pain episode. Although the present study did not 
demonstrate a gender difference, implications of the results focusing on possible 
explanations will be addressed.  
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Psychometric characteristics of BDI-FastScreen. To develop the BDI-
FastScreen, Beck factor analyzed the BDI-II, the measure from which the BDI-
FastScreen was derived (Beck et al., 2000).  Beck found that four cognitive components 
made up one factor of the BDI—II (Beck et al.,  2000).  To develop the seven items of 
the BDI-FastScreen, Beck combined DSM-IV-TR diagnostic criteria, a suicidiality 
criterion and the four cognitive factors derived from the BDI-II (Beck et al., 2000).  
These seven items made up the internal structure of the BDI-FastScreen. In the present 
study, results demonstrated the BDI-FastScreen to be comprised of one factor. There has 
been a paucity of studies validating the factor structure of the BDI-FastScreen. This 
present study puts forth a proposed factor structure of the BDI-FastScreen within a 
sample of patients with pain.  Although this factor structure may be distinctive to a 
individuals with chronic pain, differing results may be found in various other medical 
populations. However, given the small number of items, finding more than one or two 
reliable factors would be unlikely. Previous research put forth by Beck et al. produced a 
one-factor structure. Although there were no major differences in the composition of the 
pilot sample with respect to gender, other researchers have reported gender differences 
commonly found within depression.  
Gender Differences in Depression.  Previous research has been documented that 
women at an increased risk of acquiring depression symptomatology.  In addition, 
depression is the fourth-most prevalent cause of disability in women and the primary 
cause of disease-related disability  (American Psychiatric Association, 2000; 
Kessler,2003; Lazear, Pires, Isaacs, Chaulk, & Huang, 2008). Women are diagnosed 
with depression at a rate more than twice that of their male counterparts and demonstrate 
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lifetime prevalence rates 12% higher than those of men (Culbertson, 1997; Kessler et al., 
1993; Sloan & Sandt, 2006). Research has additionally demonstrated that women seek 
disability compensation 2.5 times more frequently for anxiety or depression-related 
symptoms than do men (Dewa, Lin, & Paterson, 2002).   
The results of the present study indicate that women were not more depressed 
than men and had overall low depression scores. However, although no significant effect 
was found for gender or the dichotomized category of depression on the BDI-
FastScreen, in both instances the differences did approach significance.  Actually, power 
would have increased if more participants had been in the study and would have 
possibly supported the hypothesis that women would be more depressed than men. 
Perhaps, within a sample of patients with pain, the intensity of pain washes out gender 
differences. As previous research has demonstrated, women typically express pain in 
emotional terms, whereas men report negative mood symptoms, lending support to the 
results that approached significance (Affleck et al., 1999). However, prior researchers 
have found that men and women have similar emotional reactions to pain when pain 
levels are severe (Unruh, Ritchie, & Merskey, 1999). This research may indicate that the 
population of patients with pain may be a special population for whom other factors 
equalize the gender differences. Taking into consideration the observed prevalent gender 
differences regarding depression symptomatology, this conclusion would be fair.  
Patient’s Versus Physician’s Appraisal of Depression. A significant 
relationship between the physician’s depression score and the patient’s corresponding, 
self-reported depression scores on the BDI-FastScreen was found. As discussed earlier, 
physicians tend to form opinions of a patient by relying on aspects of the patient’s 
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presenting personality and the circumstances surrounding the visit to the physician (Tait 
& Chiball, 1997). Physicians tend to report more doubt when their patients report high 
pain levels and tend to underdiagnose depression when it is present (Ani et al., 2008; 
Tait & Chiball, 1997).  Previous research has indicated that physicians may respond to a 
patient in accordance with preconceived notions they have developed. Those 
preconceived notions together with doubting demeanor and underdiagnosis of 
depression, may impede the detection and intensity of the symptoms. Although a 
positive correlation was found demonstrating that physicians and patients both report 
depression, this result does not identify the depression level or intensity of either 
appraisal.  Moreover, only approximately 12% of the variability in physician ratings of 
depression were attributable to patient appraisal of depression. This corresponding 
percentage implies that approximately 88% of the variability is attributable to other 
factors.  Perhaps, pain-management physicians are especially versed in identifying 
depression within their everyday practice; however, they lack the specificity needed to 
identify significant features more indicative of a moderate or severe depressive episode. 
As the results indicated, levels of depression may be regarded as indicators of pain 
intensity and may moderate the relationship.  
Gender as a moderator between depression and pain. Patients with minimal 
depression had significantly lower ratings of pain than those with moderate depression 
and those with mild depression had significantly lower pain levels than those with 
moderate depression levels. At low levels of depression, it was predicted that men and 
women would not differ in self-reported pain reports, whereas at high levels of 
depression, women were expected to report significantly more pain than that reported by 
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men. Although the main effect for gender was not significant, results demonstrated that 
the effect of level of depression on pain was significant.  As previous research has 
confirmed, depression is the most common comorbid condition to chronic pain (Poole et 
al., 2006; Tennen et al., 2006). Previous suppositions have been that psychological 
factors have the ability to affect the course and intensity of pain (Turk et al., 1983). It 
would stand to reason then that in a sample of 328 patients with chronic pain, depression 
would be a concomminant sequlae of symptoms. Turk et al. (1983) have long postulated 
that psychological factors may affect an individual’s perceptions of pain intensity and 
overall pain appraisal. As described in the Gate Control Theory of Pain, the pain gate is 
regulated by thoughts, feelings and behaviors. Thoughts, feelings and behaviors play an 
integral role in the pain experience (Gatchel, 2005). Melzack’s newest pain theory, the 
Neuromatrix Theory, identifies a unique manner in which brain changes occur. He 
theorizes that psychological basis of pain is extensive and that many factors, such as 
genetic factors, situational factors and sensory experiences can influence pain (Melzack, 
2005). The pain neuromatrix is the seminal mechanism for identifying and imprinting 
the sensation of pain as it focuses on all aspects of a pain experience, namely, vestibular, 
visual and somatosensory sensations (Melzack, 2005). Melzack accounts for individual 
differences in the establishment and maintenance of pain for each person. Depression,  
then, may amplify the perception and experience of pain.  Given previous theories of the 
multidimensionality and physiologic make-up of pain, this study confirms the postulate 
identifying the correlation between the intensity of depression and the reported intensity 
of pain. 
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Single-item self-rated depression descriptors. The manner in which all the 
patients self-rated the specified depression descriptors resulted in a significant correlation 
between the BDI-FastScreen scores and the items on the patient encounter form. All the 
correlations found were significant. These significant results confirm the supposition that 
breaking down the seven items into descriptors and embedding the descriptors into a 
different measure may adequately assess for depression.  These results will serve to 
increase the physician’s efficient use of time by reducing the number of measures 
administered.  
A linear combination of single-item self-rated depression descriptors as 
predictors. Overall, the self-rated measures of depression were significant indicators of 
the BDI-FastScreen total scores. Three self-rated depression descriptors, namely, 
saddening, life-ending and failure, were highly significant predictors of BDI-FastScreen 
total scores.  Overall, the combination of these three self-rated descriptors significantly 
predicted the BDI-FastScreen total. The implication of this result is that the linear 
combination of these three items is a useful indicator of depression. Administering three 
of the seven items by embedding these items within the pain questionnaire may remove 
the need for another instrument and increase efficiency.  
Factor structure of the modified SF-MPQ.  The factors of the modified SF-
MPQ accounted for more than 58% of the variance. This result basically extends previous 
research demonstrating support for this measure. These confirmatory results indicate that 
the simplicity and uniqueness of this adapted measure and its proficiency in detecting 
depression in the population with chronic pain provide pain-management physicians and 
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clinical-health psychologists with a new tool. The ease of detecting depression in this 
medical population within the context of one measure is a benefit.  
Limitations 
 
The present results demonstrate a significant correlation between physician 
ratings of patient depression and patient self-ratings as endorsed on the BDI-FastScreen. 
Although the results of the present study demonstrated potentially and clinically useful 
results, there are some noted limitations to be addressed. These limitations include factors 
such as antidepressant medication use, the rating scales, the specific type of patients who 
comprised the sample in this study, and the specialty setting in which the data were 
gathered.  
Medications prescribed to treat chronic pain may have positively affected 
depressive symptomatology of the patients in the sample. As presented in the 
demographic section, some of the participants reported taking antidepressant 
medications. Although typically antidepressant medications, prescribed by a pain 
management physician are used to assuage neuropathic pain, the potential for the 
antidepressants to additionally alleviate the depressive symptomatology should not be 
discounted in the present instance. Usually the antidepressant medications used in this 
manner are not prescribed at a therapeutic dosage for depression, but they may have 
added a possible confound in the present study. Future research should be conducted with 
a sample of patients with chronic pain who are not taking any antidepressant medications.  
The directions on the BDI-FastScreen and the encounter sheet requested that the 
patient answer the presented questions on a four-point scale by circling the most 
appropriate answer. The directions called for the patient to recall and rate their pain over 
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the past 2 weeks. Patients may not have been very good historians and their answers may 
or may not have been consistent with their present mood.  
Given the nature of the sample being studied, there is also a possibility that these 
patients at the time of the appointment may have been experiencing a deficit of coping 
skills, an extreme amount of pain, or dissatisfaction with the progress of their treatment. 
Those three factors alone may make completion of the measures difficult. Although 
depression measures are structured to assess for a depressive episode, the professional 
must remember to use clinical judgment. Depressive symptoms may be reported 
particularly within a population of patients with chronic pain; however, these symptoms 
may be a reaction to a loss of previous functioning or a reaction to the pain itself. 
Previous researchers have suggested that the development of depression may be initially 
the result of situational factors (Gatchel & Turk, 1996).  However, situational factors may 
act indirectly on psychological and social factors thereby exacerbating the pain symptoms 
and cognitive interpretations (Bandura, Taylor, Williams, Mefford, & Barchas, 1985).  
Keeping in mind, when addressing this population, that pain is multidimensional is of 
great importance. The pain experience is related not only to the intensity of pain the 
patient feels that particular day, but also to the patient’s personal, internal definition of 
pain. As with any intrapersonal definition, there is potential for irrelevant information to 
become a factor in the patient’s definition of pain. Awareness, memory, and expectations 
are three concepts that should be considered, as they contribute to the individual’s 
perception of pain. Potentially, a patient with chronic pain may experience greater 
hopelessness, pessimism, and despair than a patient without chronic pain.  
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Environmental aspects must also be considered as well when addressing 
limitations within this medical population.  The location of the testing also must be taken 
into consideration. The participants were required to complete the measures in a 
physician’s office. The physical location whether a waiting room with other patients 
around or an exam room which is stark, cold and uncomfortable, may have contributed to 
the pain level that the patient was experiencing. Additionally, there is the possibility that 
the participants may not have been completely honest, fearing that honesty could 
negatively impact their treatment. The self-report measure also may have produced a 
dishonest answer, especially when taking the BDI-FastScreen because the participants 
knew that they were taking a depression inventory.  
This study included patients who were established patients in the practice.  
Therefore, the probability that the patients had been previously exposed to and had 
completed the encounter form is high, as this form is an established measure in this 
medical practice. This experience may have affected their responses. Additionally, there 
is a significant chance that the patient had been exposed to and taken the BDI-FastScreen. 
Thus, there is a possibility that the patients either knew or anticipated what the physicians 
were looking for when they patients completed the measures.  
The final limitation of the present study is a related to sample diversity. The 
sample used was a sample of convenience: established patients in a pain practice. Most of 
the sample was comprised of Caucasians patients with pain and, hence, the results may 
not generalize to patients from large metropolitan areas or ethnically diverse populations. 
Thus, the findings may be difficult to generalize to the population with chronic pain as a 
whole. Owing to the breadth of the term, chronic pain, the illnesses that were included in 
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this category encompassed a wide variety of medical diagnoses, such as chronic back 
pain, arthritis pain, migraine pain, and myofascial pain.  
Implications for Practice 
 
 The purposes of this study were to extend previous literature on the BDI-
FastScreen and to demonstrate a more empirical clinical utility within a sample of 
patients with pain. Results of this project demonstrated that the BDI-FastScreen can be 
condensed to one-word descriptors and adequately assess for depression in a population 
with chronic pain. Instead of utilizing the data from two distinct measures, the adapted 
patient encounter form, a derivative of the SF-MPQ and the BDI-FastScreen, both 
clinical disorders can be expeditiously and adequately assessed with only the derivative 
of the SF-MPQ. Higher rates of depression have been found in populations of general 
medical patients; therefore, a measure that has been demonstrated to assess for depression 
in various medical patients has the potential to screen and ultimately reduce depression 
symptomatology found in medical settings (Clark et al., 1998; Freeman et al., 2010). 
Coexisting depression symptoms can exacerbate medical symptoms and negatively affect 
social adjustment and medical and psychological recovery. Therefore, the clinical utility 
of this measure can enhance the physician’s ability to detect depression in various 
treatment settings.   
Primary care may be a medical setting in which these depression predictors may 
be particularly helpful. As this measure has been demonstrated to detect depression in a 
population with chronic pain, it may additionally be helpful in detecting depression in a 
primary-care setting.  Given the strong comorbid association of depression and pain 
symptomatology found in a primary-care setting, this may prove to be an efficacious 
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assessment measure within this medical setting.  The linear combination of the three, 
one-word descriptors may provide primary-care physicians with an effective assessment 
tool designed to identify significant pain and depression symptoms.   
While it has been established that CBT is a beneficial treatment modality for both 
depression and pain, this current research provides a measure that can be rapidly 
administered and easily interpreted to facilitate appropriate treatment planning (Miranda, 
et al., 2006; Scascighini et al.,  2008).  The sooner the depression is detected and 
diagnosed, the quicker CBT or other available treatments can be implemented. 
Future Research  
Given the present findings results, some possible future directions of this research 
might include specifying subgroups within the population of patients with chronic pain 
who share a given diagnosis (e.g., arthritis) and validating this measure within these 
groups. For example, a population of patients with chronic back pain may demonstrate 
results that differ from those shown by a population of patients with migraine pain.  
There are multiple groups with which this type of validation can be achieved.  Such 
potential research may ultimately help to identify differences across diagnostic groups 
which, in turn, may better inform treatment decisions.   
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